Document_and_Entity_Informatio
Document and Entity Information (USD $) | 12 Months Ended | ||
In Millions, except Share data, unless otherwise specified | Dec. 31, 2013 | Feb. 28, 2014 | Jun. 30, 2013 |
Document and Entity Information [Abstract] | ' | ' | ' |
Entity Registrant Name | 'GigOptix, Inc. | ' | ' |
Entity Central Index Key | '0001432150 | ' | ' |
Current Fiscal Year End Date | '--12-31 | ' | ' |
Entity Well-known Seasoned Issuer | 'No | ' | ' |
Entity Voluntary Filers | 'No | ' | ' |
Entity Current Reporting Status | 'Yes | ' | ' |
Entity Filer Category | 'Smaller Reporting Company | ' | ' |
Entity Public Float | ' | ' | $28.70 |
Entity Common Stock, Shares Outstanding | ' | 32,178,795 | ' |
Document Fiscal Year Focus | '2013 | ' | ' |
Document Fiscal Period Focus | 'FY | ' | ' |
Document Type | '10-K | ' | ' |
Amendment Flag | 'false | ' | ' |
Document Period End Date | 31-Dec-13 | ' | ' |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $20,377 | $10,147 |
Accounts receivable, net | 5,021 | 5,056 |
Inventories | 4,617 | 4,111 |
Prepaid and other current assets | 434 | 295 |
Total current assets | 30,449 | 19,609 |
Property and equipment, net | 2,999 | 4,579 |
Intangible assets, net | 3,287 | 4,270 |
Goodwill | 9,860 | 9,860 |
Restricted cash | 284 | 282 |
Other assets | 183 | 228 |
Total assets | 47,062 | 38,828 |
Current liabilities: | ' | ' |
Accounts payable | 831 | 3,174 |
Accrued compensation | 1,170 | 846 |
Line of credit | 0 | 3,600 |
Other current liabilities | 2,746 | 3,080 |
Total current liabilities | 4,747 | 10,700 |
Capital lease, noncurrent | 10 | 281 |
Pension liabilities | 140 | 252 |
Deferred rent, noncurrent | 177 | 233 |
Other long term liabilities | 408 | 362 |
Total liabilities | 5,482 | 11,828 |
Commitments and contingencies (Note 12) | ' | ' |
Stockholders' equity: | ' | ' |
Preferred stock, $0.001 par value; 1,000,000 shares authorized; no shares issued and outstanding as of December 31, 2013 and 2012 | 0 | 0 |
Common stock, $0.001 par value; 50,000,000 shares authorized as of December 31, 2013 and 2012; 32,067,616 and 22,205,746 shares issued and outstanding as of December 31, 2013 and 2012, respectively | 32 | 22 |
Additional paid-in capital | 139,710 | 123,386 |
Treasury stock, at cost; 701,754 shares as of December 31, 2013 and 2012, respectively | -2,209 | -2,209 |
Accumulated other comprehensive income | 490 | 298 |
Accumulated deficit | -96,443 | -94,497 |
Total stockholders' equity | 41,580 | 27,000 |
Total liabilities and stockholders' equity | $47,062 | $38,828 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
Stockholders' equity: | ' | ' |
Preferred stock, par value (in dollars per share) | $0.00 | $0.00 |
Preferred stock, authorized (in shares) | 1,000,000 | 1,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Preferred stock, outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $0.00 | $0.00 |
Common stock, authorized (in shares) | 50,000,000 | 50,000,000 |
Common stock, issued (in shares) | 32,067,616 | 22,205,746 |
Common stock, outstanding (in shares) | 32,067,616 | 22,205,746 |
Treasury Stock, at cost (in shares) | 701,754 | 701,754 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 12 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Revenue | ' | ' |
Product | $24,841 | $33,308 |
Development fees and other | 4,085 | 3,426 |
Total revenue | 28,926 | 36,734 |
Total cost of revenue | 11,522 | 16,941 |
Gross profit | 17,404 | 19,793 |
Research and development expense | 13,878 | 13,516 |
Selling, general and administrative expense | 9,388 | 11,709 |
Restructuring expense | 950 | 93 |
Special litigation-related income (expense) | -4,786 | 1,351 |
Total operating expenses | 19,430 | 26,669 |
Loss from operations | -2,026 | -6,876 |
Interest expense, net | -127 | -267 |
Other income, net | 257 | 220 |
Loss before provision for income taxes | -1,896 | -6,923 |
Provision for income taxes | 50 | 81 |
Net loss | ($1,946) | ($7,004) |
Net loss per share-basic and diluted (in dollars per share) | ($0.09) | ($0.33) |
Weighted average number of shares used in per share calculations - basic and diluted (in shares) | 21,826 | 21,444 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS [Abstract] | ' | ' |
Net loss | ($1,946) | ($7,004) |
Other comprehensive income (loss), net of tax | ' | ' |
Foreign currency translation adjustment | 91 | -16 |
Change in pension liability in connection with actuarial gain (loss) | 101 | -109 |
Other comprehensive income (loss), net of tax | 192 | -125 |
Comprehensive loss | ($1,754) | ($7,129) |
CONSOLIDATED_STATEMENTS_OF_STO
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $) | Common Stock [Member] | Treasury Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Accumulated Other Comprehensive Income [Member] | Total |
In Thousands, except Share data, unless otherwise specified | ||||||
Balance at Dec. 31, 2011 | $22 | $0 | $118,362 | ($87,493) | $423 | $31,314 |
Balance (in shares) at Dec. 31, 2011 | 21,545,713 | 0 | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' |
Stock-based compensation | 0 | 0 | 5,087 | 0 | 0 | 5,087 |
Issuance of common stock in connection with exercise of options | 0 | 0 | 400 | 0 | 0 | 400 |
Issuance of common stock in connection with exercise of options (in shares) | 230,466 | 0 | ' | ' | ' | ' |
Issuance of common stock in connection with exercise of warrants | 0 | 0 | 0 | 0 | 0 | 0 |
Issuance of common stock in connection with exercise of warrants (in shares) | 14,158 | 0 | ' | ' | ' | ' |
Issuance of restricted stock to employees, net of taxes paid related to net share settlement of equity awards | 0 | 0 | -463 | 0 | 0 | -463 |
Issuance of restricted stock to employees, net of taxes paid related to net share settlement of equity awards (in shares) | 415,409 | 0 | ' | ' | ' | ' |
Purchase of treasury stock, including direct issuance costs | ' | -2,209 | 0 | 0 | 0 | -2,209 |
Purchase of treasury stock, including direct issuance costs (in shares) | ' | 701,754 | ' | ' | ' | ' |
Foreign currency translation adjustment | 0 | 0 | 0 | 0 | -16 | -16 |
Change in pension liability in connection with actuarial gain, net of tax | 0 | 0 | 0 | 0 | -109 | -109 |
Net loss | 0 | 0 | 0 | -7,004 | 0 | -7,004 |
Balance at Dec. 31, 2012 | 22 | -2,209 | 123,386 | -94,497 | 298 | 27,000 |
Balance (in shares) at Dec. 31, 2012 | 22,205,746 | 701,754 | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' |
Stock-based compensation | 0 | 0 | 4,216 | 0 | 0 | 4,216 |
Issuance of common stock in connection with exercise of options | 0 | 0 | 13 | 0 | 0 | 13 |
Issuance of common stock in connection with exercise of options (in shares) | 12,221 | 0 | ' | ' | ' | ' |
Issuance of restricted stock to employees, net of taxes paid related to net share settlement of equity awards | 0 | 0 | -194 | 0 | 0 | -194 |
Issuance of restricted stock to employees, net of taxes paid related to net share settlement of equity awards (in shares) | 275,899 | 0 | ' | ' | ' | ' |
Issuance of common stock in connection with the public offering, net of direct issuance costs | 10 | ' | 12,289 | ' | ' | 12,299 |
Issuance of common stock in connection with the public offering, net of direct issuance costs (in shares) | 9,573,750 | ' | ' | ' | ' | ' |
Foreign currency translation adjustment | 0 | 0 | 0 | 0 | 91 | 91 |
Change in pension liability in connection with actuarial gain, net of tax | 0 | 0 | 0 | 0 | 101 | 101 |
Net loss | 0 | 0 | 0 | -1,946 | 0 | -1,946 |
Balance at Dec. 31, 2013 | $32 | ($2,209) | $139,710 | ($96,443) | $490 | $41,580 |
Balance (in shares) at Dec. 31, 2013 | 32,067,616 | 701,754 | ' | ' | ' | ' |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Cash flows from operating activities: | ' | ' |
Net loss | ($1,946) | ($7,004) |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ' | ' |
Depreciation and amortization | 3,882 | 4,085 |
Stock-based compensation | 4,216 | 5,087 |
Change in fair value of warrants | -9 | 3 |
Non-cash restructuring benefits | 0 | -114 |
Net gain on sale of property and equipment | -118 | -163 |
Changes in operating assets and liabilities, net of acquisition: | ' | ' |
Accounts receivable, net | 35 | 569 |
Inventories | -506 | -1,606 |
Prepaid and other current assets | -797 | -385 |
Other assets | 45 | 80 |
Accounts payable | -1,462 | 46 |
Accrued restructuring | -140 | -290 |
Accrued compensation | 324 | 14 |
Other current liabilities | -83 | -2,470 |
Other long-term liabilities | -120 | 172 |
Net cash provided by (used in) operating activities | 3,321 | -1,976 |
Cash flows from investing activities: | ' | ' |
Proceeds from sale and maturity of investments | 0 | 400 |
Purchases of property and equipment | -1,536 | -1,961 |
Proceeds from sale of property and equipment | 160 | 90 |
Change in restricted cash | 0 | -25 |
Net cash used in investing activities | -1,376 | -1,496 |
Cash flows from financing activities: | ' | ' |
Proceeds from public offering of stock, net of cost | 12,299 | 0 |
Proceeds from issuance of stock | 13 | 400 |
Taxes paid related to net share settlement of equity awards | -194 | -463 |
Net borrowings (repayment) on line of credit | -3,600 | 600 |
Repayment of capital lease | -405 | -425 |
Purchases of treasury stock, including direct issuance costs | 0 | -2,209 |
Net cash provided by (used in) financing activities | 8,113 | -2,097 |
Effect of exchange rates on cash and cash equivalents | 172 | -72 |
Net increase (decrease) in cash and cash equivalents | 10,230 | -5,641 |
Cash and cash equivalents at beginning of period | 10,147 | 15,788 |
Cash and cash equivalents at end of period | 20,377 | 10,147 |
Supplemental disclosure of cash flow information | ' | ' |
Interest paid | 127 | 267 |
Property, plant and equipment acquired under capital lease | 13 | 0 |
Property, plant and equipment acquired with accounts payable | $23 | $874 |
ORGANIZATION_AND_BASIS_OF_PRES
ORGANIZATION AND BASIS OF PRESENTATION | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
ORGANIZATION AND BASIS OF PRESENTATION [Abstract] | ' | ||||||||
ORGANIZATION AND BASIS OF PRESENTATION | ' | ||||||||
NOTE 1—ORGANIZATION AND BASIS OF PRESENTATION | |||||||||
Organization | |||||||||
GigOptix Inc. (“GigOptix” or the “Company”) is a leading fabless supplier of high speed semiconductor components that enable end-to-end information streaming over optical and wireless networks and address long haul and metro telecommunications applications as well as emerging high-growth opportunities for Cloud and datacenter connectivity, interactive applications for consumer electronics, high-speed optical and wireless networks, and the industrial, defense and avionics industries. The business is made up of two product lines: the High-Speed Communications (“HSC”) product line and the Industrial product line. | |||||||||
The HSC product line offers a broad portfolio of high performance optical and wireless components to telecommunications (“telecom”) and data communications (“datacom”) customers, i) mixed signal radio frequency integrated circuits (“RFIC”), including 10 to 400 gigabit per second (“Gbps”) laser and optical drivers and trans-impedance amplifiers (“TIA”) for telecom, datacom, and consumer electronic fiber-optic applications; ii) power amplifiers and transceivers for microwave and millimeter monolithic microwave integrated circuit (“MMIC”) wireless applications including 73 Ghz and 83 GHz power amplifiers and transceiver chips; and iii) integrated systems in a package (“SIP”) solutions for both fiber-optic and wireless applications. The HSC product line also partners with key customers on development projects that generate engineering project revenue for the Company while helping to position the Company for future product revenues with these key customers. | |||||||||
The Industrial product line offers a wide range of digital and mixed-signal application specific integrated circuit (“ASIC”) solutions for industrial, military, avionics, medical and communications markets. The Industrial product line partners with ASIC customers on development projects that generate engineering project revenue for the Company which generally leads to future product revenues with these ASIC customers. | |||||||||
The Company’s products focus on the specification, design, development and sale of analog semiconductor integrated circuits (“ICs”), multi-chip module (“MCM”) solutions, and digital and mixed signal ASICs, as well as wireless communications MMICs and modules. | |||||||||
GigOptix, Inc., the successor to GigOptix LLC, was formed as a Delaware corporation in March 2008 in order to facilitate a combination between GigOptix LLC and Lumera Corporation (“Lumera”). Before the combination, GigOptix LLC acquired the assets of iTerra Communications LLC in July 2007 (“iTerra”) and Helix Semiconductors AG (“Helix”) in January 2008. On November 9, 2009, GigOptix acquired ChipX, Incorporated (“ChipX”). On June 17, 2011, GigOptix acquired Endwave Corporation (“Endwave”). As a result of the acquisitions, Helix, Lumera, ChipX and Endwave all became wholly owned subsidiaries of GigOptix. | |||||||||
GigOptix Gmbh | |||||||||
In March 2013, the Company established a German subsidiary, GigOptix GmbH. The subsidiary is engaged in research and development for the Company’s HSC product line including electro-optical products. | |||||||||
Reclassifications | |||||||||
Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, stockholders’ equity, net loss or net cash used in operating activities. | |||||||||
Basis of Presentation | |||||||||
The Company’s fiscal year ends on December 31. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. | |||||||||
Use of Estimates | |||||||||
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“US GAAP”) requires management to make estimates, judgments and assumptions that affect the reported amount of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an on-going basis, the Company evaluates its estimates, including those related to allowances for doubtful accounts, reserves for stock rotation rights, warranty accrual, inventory write-downs, valuation of long-lived assets, including property and equipment and identified intangible assets and goodwill, valuation of deferred taxes and contingencies. In addition, the Company uses assumptions when employing the Black-Scholes option-pricing model to calculate the fair value of stock options granted; and assumptions when employing the Monte Carlo simulation to estimate the carrying value of its warrant liability. The Company bases its estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources. Actual results could differ from these estimates. | |||||||||
Certain Significant Risks and Uncertainties | |||||||||
The Company operates in a dynamic industry and, accordingly, its business can be affected by a variety of factors. For example, changes in any of the following areas could have a negative effect in terms of its future financial position, results of operations or cash flows: a downturn in the overall semiconductor industry or communications semiconductor market; regulatory changes; fundamental changes in the technology underlying telecom products or incorporated in customers’ products; market acceptance of its products under development; litigation or other claims against the Company; litigation or other claims made by the Company; the hiring, training and retention of key employees; integration of businesses acquired; successful and timely completion of product development efforts; and new product introductions by competitors. | |||||||||
Fair Value of Financial Instruments | |||||||||
The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, and other accrued liabilities. The Company regularly reviews its investment portfolio to identify and evaluate investments that have indications of possible impairment. Factors considered in determining whether a loss is temporary include: the length of time and extent to which fair value has been lower than the cost basis; the financial condition, credit quality and near-term prospects of the investee; and whether it is more likely than not that the Company will be required to sell the security prior to any anticipated recovery in fair value. When there is no readily available market data, fair value estimates may be made by the Company, which may not necessarily represent the amounts that could be realized in a current or future sale of these assets. | |||||||||
Revenue Recognition | |||||||||
Revenue from sales of optical drivers and receivers, multi-chip modulators, and other products is recognized when persuasive evidence of a sales arrangement exists, transfer of title occurs, the sales price is fixed or determinable and collection of the resulting receivable is reasonably assured. Provisions are made for warranties at the time revenue is recorded. See Note 12—Commitments and Contingencies for further detail related to the warranty provision. | |||||||||
Customer purchase orders are generally used to determine the existence of an arrangement. Transfer of title and risk of ownership occur based on defined terms in customer purchase orders, and generally pass to the customer upon shipment, at which point goods are delivered to a carrier. There are no formal customer acceptance terms or further obligations, outside of standard product warranty. The Company assesses whether the sales price is fixed or determinable based on the payment terms associated with the transaction. Collectibility is assessed based primarily on the credit worthiness of the customer as determined through ongoing credit evaluations of the customer’s financial condition, as well as consideration of the customer’s payment history. | |||||||||
The Company records revenue from non-recurring engineering projects associated with product development that the Company enters into with certain customers. In general, these projects are associated with complex technology development, and as such the Company does not have certainty about its ability to achieve the program milestones. Achievement of the milestone is dependent on the Company’s performance and is typically accepted by the customer. The payment associated with achieving the milestone is generally commensurate with the Company’s effort or the value of the deliverable and is nonrefundable. Therefore, the Company records the expenses related to these projects in the periods incurred and recognizes revenue only when the Company has earned the revenue and achieved the development milestones. Revenue from these projects are typically recorded at 100% gross margin because the costs associated with these projects are expensed as incurred and generally included in research and development expense. These efforts generally benefit the Company’s overall product development programs beyond the specific project requested by our customer. | |||||||||
The Company sells some products to distributors at the price listed in its price book for that distributor. The Company's distributor agreements provide for semi-annual stock rotation privileges of 5% to 10% of net sales for the previous six-month period. At the time of sale, the Company records a sales reserve for stock rotations approved by management. The Company offsets the sales reserve against revenues, producing the net revenue amount reported in the consolidated statements of operations. Each month the Company adjusts the sales reserve for the estimated stock rotation privilege anticipated to be utilized by the distributors. When the distributors pay the Company's invoices, they may claim stock rotations when appropriate. Once claimed, the Company processes the requests against the prior authorizations and reduces the reserve previously established for that customer. As of December 31, 2013 and 2012, the reserve for stock rotations was $151,000 and $65,000, respectively, and is recorded in other current liabilities on the consolidated balance sheets. | |||||||||
The Company records transaction-based taxes including, but not limited to, sales, use, value added, and excise taxes, on a net basis in its consolidated statements of operations. | |||||||||
Accounts Receivable and Allowance for Doubtful Accounts | |||||||||
Accounts receivable are recorded at the invoiced amount and are not interest bearing. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectibility of its accounts receivable in its calculation of the allowance for doubtful accounts. In determining the amount of the allowance, the Company makes judgments about the creditworthiness of customers based on ongoing credit evaluations and assesses current economic trends affecting its customers that might impact the level of credit losses in the future and result in different rates of bad debts than previously seen. The Company also considers its historical level of credit losses. As of December 31, 2013, the Company’s accounts receivable balance was $5.0 million, which was net of an allowance for doubtful accounts of $220,000. As of December 31, 2012, the Company’s accounts receivable balance was $5.1 million, which was net of an allowance for doubtful accounts of $337,000. | |||||||||
Cash and Cash Equivalents | |||||||||
The Company considers all highly liquid investments with an original maturity of 90 days or less at the date of purchase to be cash equivalents. Cash and cash equivalents are maintained at various financial institutions. | |||||||||
Concentration of Credit Risk | |||||||||
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company maintains cash and cash equivalents with various financial institutions that management believes to be of high credit quality. At any time, amounts held at any single financial institution may exceed federally insured limits. The Company believes that the concentration of credit risk in its accounts receivable is substantially mitigated by its credit evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary but generally requires no collateral. | |||||||||
As of December 31, 2013, two customers accounted for 29% and 17% of total accounts receivable. As of December 31, 2012, one customer accounted for 31% of total accounts receivable. | |||||||||
For the year ended December 31, 2013, one customer accounted for 33% of total revenue. For the year ended December 31, 2012, two customers accounted for 22% and 12% of total revenue. | |||||||||
Concentration of Supply Risk | |||||||||
The Company relies on third parties to manufacture its products, and depends on them for the supply and quality of its products. Quality or performance failures of the Company’s products or changes in its manufacturers’ financial or business condition could disrupt the Company’s ability to supply quality products to its customers and thereby have a material and adverse effect on its business and operating results. Some of the components and technologies used in the Company’s products are purchased and licensed from a single source or a limited number of sources. The loss of any of these suppliers may cause the Company to incur additional transition costs, result in delays in the manufacturing and delivery of its products, or cause it to carry excess or obsolete inventory or redesign its products. The Company relies on a third party for the fulfillment of its customer orders, and the failure of this third party to perform could have an adverse effect upon the Company’s reputation and its ability to distribute its products, which could adversely affect the Company’s business. | |||||||||
Inventories | |||||||||
Inventories are stated at the lower of standard cost, which approximates actual cost on a first-in, first-out basis, or market (net realizable value). Cost includes labor, material and overhead costs. Determining fair market value of inventories involves numerous judgments, including projecting average selling prices and sales volumes for future periods and costs to complete products in work in process inventories. As a result of this analysis, when fair market values are below costs, the Company records a charge to cost of revenue in advance of when the inventory is scrapped or sold. | |||||||||
The Company evaluates its ending inventories for excess quantities and obsolescence on a quarterly basis. This evaluation includes analysis of historical and forecasted sales levels by product against inventories on-hand. Inventories on-hand in excess of estimated future demand are reviewed by management to determine if a write-down is required. In addition, the Company writes-off inventories that are considered obsolete. Obsolescence is determined from several factors, including competitiveness of product offerings, market conditions and product life cycles when determining obsolescence. Excess and obsolete inventories are charged to cost of revenue and a new, lower-cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. | |||||||||
The Company’s inventories include high-technology parts that may be subject to rapid technological obsolescence and which are sold in a highly competitive industry. If actual product demand or selling prices are less favorable than forecasted amounts, the Company may be required to take additional inventory write-downs. | |||||||||
Property and Equipment | |||||||||
Property and equipment, including leasehold improvements, are recorded at cost and depreciated using the straight-line method over their estimated useful lives, ranging from one to seven years. Leasehold improvements and assets acquired under capital leases are depreciated over the lesser of their estimated useful lives or the remaining lease term of the respective assets. Repairs and maintenance costs are charged to expenses as incurred. | |||||||||
Long-lived Assets | |||||||||
Long-lived assets include equipment, furniture and fixtures, licenses, leasehold improvements, semiconductor masks used in production and intangible assets. When events or changes in circumstances indicate that the carrying amount of long-lived assets may not be recoverable, the Company tests for recoverability by comparing the estimate of undiscounted cash flows to be generated by the assets against the assets’ carrying amount. If the carrying value exceeds the estimated future cash flows, the assets are considered to be impaired. The amount of impairment equals the difference between the carrying amount of the assets and their fair value. Factors the Company considers important that could trigger an impairment review include continued operating losses, significant negative industry trends, significant underutilization of the assets and significant changes in how it plans to use the assets. | |||||||||
Intangible assets are amortized on a straight-line basis over their estimated economic lives of six to seven years for existing technology, acquired in business combinations; five to sixteen years for patents acquired in business combinations, based on the term of the patent or the estimated useful life, whichever is shorter; one year for order backlog, acquired in business combinations; ten years for trade name, acquired in business combinations; and three to eight years for customer relationships, acquired in business combinations. | |||||||||
Goodwill | |||||||||
Goodwill is recorded when the purchase price of an acquisition exceeds the fair value of the net purchased tangible and intangible assets acquired and is carried at cost. Goodwill is not amortized, but is reviewed annually for impairment. The Company performs its annual goodwill impairment analysis in the fourth quarter of each year or more frequently if it believes indicators of impairment exist. Factors that it considers important which could trigger an impairment review include the following: | |||||||||
· | significant underperformance relative to historical or projected future operating results; | ||||||||
· | significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition; | ||||||||
· | significant negative industry or economic trends; and | ||||||||
· | significant decline in the Company’s market capitalization. | ||||||||
When evaluating goodwill for impairment, the Company may initially perform a qualitative assessment which includes a review and analysis of certain quantitative factors to estimate if a reporting units’ fair value significantly exceeds its carrying value. When the estimate of a reporting unit’s fair value appears more likely than not to be less than its carrying value based on this qualitative assessment, the Company continues to the first step of a two step impairment test. The first step requires a comparison of the fair value of the reporting unit to its net book value, including goodwill. The fair value of the reporting units is determined based on a weighting of income and market approaches. Under the income approach, the Company calculates the fair value of a reporting unit based on the present value of estimated future cash flows. Under the market approach, the Company estimates the fair value based on market multiples of revenue or earnings for comparable companies. Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, and future economic and market conditions and determination of appropriate market comparables. The Company bases these fair value estimates on reasonable assumptions but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates. A potential impairment exists if the fair value of the reporting unit is lower than its net book value. The second step of the process is only performed if a potential impairment exists, and it involves determining the difference between the fair values of the reporting unit’s net assets, other than goodwill, and the fair value of the reporting unit, and, if the difference is less than the net book value of goodwill, an impairment charge is recorded. In the event that the Company determines that the value of goodwill has become impaired, it will record a charge for the amount of impairment during the fiscal quarter in which the determination is made. The Company operates in one reporting unit. The Company conducted its 2013 annual goodwill impairment analysis in the fourth quarter of 2013 and no goodwill impairment was indicated. | |||||||||
Restricted Cash | |||||||||
Restricted cash as of December 31, 2013 and 2012 consists of $284,000 and $282,000, respectively, which includes $151,000 in satisfaction of the letter of credit provisions of the Company’s Bothell, Washington facility lease which has a lease term ending the first quarter of 2014, $58,000 and $56,000, respectively, held in an escrow account related to its facility lease in Zurich, Switzerland, for which it is management’s expectation to continue to renew this lease beyond the current year and $75,000 with Silicon Valley Bank to secure its credit card. Restricted cash is held in interest-bearing cash accounts and is classified as long term. | |||||||||
Pension Liabilities | |||||||||
The Company maintains a defined benefit pension plan covering minimum requirements according to Swiss law for its Zurich, Switzerland employees. The Company recognizes the funded status of its defined benefit pension plan on its consolidated balance sheets and changes in the funded status are reflected in accumulated other comprehensive income, net of tax, a component of stockholders’ equity. | |||||||||
Net periodic pension costs are calculated based upon a number of actuarial assumptions, including a discount rate for plan obligations, assumed rate of return on pension plan assets and assumed rate of compensation increases for plan employees. All of these assumptions are based upon management’s judgment, considering all known trends and uncertainties. Actual results that differ from these assumptions would impact the future expense recognition and cash funding requirements of its pension plans. | |||||||||
Foreign Currency | |||||||||
The financial position and results of operations of the Company’s foreign subsidiaries are measured using the local currency as their functional currency. Accordingly, all assets and liabilities for these subsidiaries are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Revenue and expense items are translated at the average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these subsidiaries’ financial statements are reported as a separate component of accumulated other comprehensive income, net of tax, a component of stockholders’ equity. The Company records foreign currency transaction gains and losses, realized and unrealized, in other income (expense), net in the consolidated statements of operations. The Company recorded approximately $11,000 of net transaction loss in 2013 and $41,000 of net transaction gain in 2012. | |||||||||
Product Warranty | |||||||||
The Company’s products typically carry a standard warranty period of approximately one year which provides for the repair, rework or replacement of products (at its option) that fail to perform within stated specification. The Company provides for the estimated cost to repair or replace the product at the time of sale. The warranty accrual is estimated based on historical claims and assumes that it will replace products subject to claims. | |||||||||
Shipping Costs | |||||||||
The Company charges shipping costs to cost of revenue as incurred. | |||||||||
Research and Development Expense | |||||||||
Research and development expenses are expensed as incurred. Research and development expense consists primarily of salaries and related expenses for research and development personnel, consulting and engineering design, non-capitalized tools and equipment, engineering related semiconductor masks, depreciation for equipment, engineering expenses paid to outside technology development suppliers, allocated facilities costs and expenses related to stock-based compensation. | |||||||||
Advertising Expense | |||||||||
Advertising costs are expensed as incurred. Advertising expenses, which are recorded in selling, general and administrative expenses, were approximately $46,000 and $66,000 for the years ended December 31, 2013 and 2012, respectively. | |||||||||
Stock-Based Compensation | |||||||||
Stock-based compensation is measured at the date of grant, based on the fair value of the award. For options, the Company amortizes the compensation costs on a straight-line basis over the requisite service period of the option, which is generally the option vesting term of four years. For restricted stock units (“RSU”), the Company amortizes the compensation costs on a straight-line basis over the requisite service period of the RSU grant, which is generally the vesting term of one to four years. The benefits of tax deductions in excess of recognized compensation expense are reported as a financing cash flow. All of the stock compensation is accounted for as an equity instrument. | |||||||||
For RSUs, stock-based compensation is based on the fair value of the Company’s common stock at the grant date. | |||||||||
Stock-based compensation expense is measured at grant date, based on the estimated fair value of the awards ultimately expected to vest and is recognized as an expense, on a straight-line basis, over the requisite service period. The Company uses the Black-Scholes option-pricing model to measure the fair value of its stock-based awards utilizing various assumptions with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield. | |||||||||
Management estimates expected forfeitures and it records the stock compensation expense only for those equity awards expected to vest. When estimating forfeitures, the Company considers voluntary termination behavior as well as an analysis of actual option forfeitures. Forfeitures are required to be estimated at the time of grant and revised if necessary in subsequent periods if actual forfeitures or vesting differ from those estimates. Such revisions could have a material effect on its operating results. The assumptions the Company uses in the valuation model are based on subjective future expectations combined with management judgment. If any of the assumptions used in the Black-Scholes option-pricing model changes significantly, stock-based compensation for future awards may differ materially compared to the awards granted previously. | |||||||||
The fair value of RSUs granted is the product of the number of shares granted and the grant date fair value of the Company’s common stock. RSUs are converted into shares of the Company’s common stock upon vesting on a one-for-one basis. Typically, vesting of RSUs is subject to the employee's continuing service to the Company. RSUs generally vest over a period of one to four years and are expensed ratably on a straight-line basis over their respective vesting period net of estimated forfeitures. | |||||||||
Warrants | |||||||||
Warrants issued as equity awards are recorded based on the estimated fair value of the awards at the grant date. The Company uses the Black-Scholes option-pricing model to measure the fair value of its equity warrant awards utilizing various assumptions with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield. | |||||||||
Warrants with certain features, including down-round protection, are recorded as liability awards. These warrants are valued using a Black-Scholes option-pricing model which requires various assumptions with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield. The warrants are recorded as a liability each reporting period, and the change in the fair value of the liability is recorded as other income (expense), net until the warrant is exercised or cancelled. | |||||||||
Net Loss per Share | |||||||||
Basic net loss per share is computed using the weighted average number of common shares outstanding. The number of shares used in the computation of diluted net loss per share is the same as those used for the computation of basic net loss per share as the inclusion of dilutive securities would be anti-dilutive because the Company is in a loss position for the periods presented. Potentially dilutive securities are composed of the incremental common shares issuable upon the exercise of stock options and the vesting of RSUs awards. For purposes of the diluted net loss per share calculation, RSUs, stock options to purchase common stock and warrants to purchase common stock are considered to be dilutive securities. | |||||||||
Income Taxes | |||||||||
The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax basis of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. | |||||||||
The calculation of tax liabilities involves dealing with uncertainties in the application of complex global tax regulations. The Company recognizes potential liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on its estimate of whether, and the extent to which, additional taxes will be due. If payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when it determines the liabilities are no longer necessary. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result. | |||||||||
Comprehensive Income (Loss) | |||||||||
Comprehensive income (loss) is comprised of two components: net loss and other comprehensive income (loss). Other comprehensive income (loss) refers to revenues, expenses, gains and losses that under U.S. GAAP are recorded as an element of stockholders’ equity, but are excluded from net loss. Accumulated other comprehensive income in the accompanying consolidated balance sheets includes foreign currency translation adjustments arising from the consolidation of the Company’s foreign subsidiaries and its pension liabilities. Comprehensive income (loss) is presented net of income tax and the tax impact is immaterial. | |||||||||
The components of accumulated other comprehensive income (loss) were as follows (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Accumulated comprehensive income: | |||||||||
Foreign currency translation adjustment, net of tax | $ | 353 | $ | 262 | |||||
Change in pension liability in connection with actuarial gain, net of tax | 137 | 36 | |||||||
Total | $ | 490 | $ | 298 |
BALANCE_SHEET_COMPONENTS
BALANCE SHEET COMPONENTS | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
BALANCE SHEET COMPONENTS [Abstract] | ' | |||||||||||
BALANCE SHEET COMPONENTS | ' | |||||||||||
NOTE 2—BALANCE SHEET COMPONENTS | ||||||||||||
Accounts receivable, net, consisted of the following, as of (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Accounts receivable | $ | 5,241 | $ | 5,393 | ||||||||
Allowance for doubtful accounts | (220 | ) | (337 | ) | ||||||||
$ | 5,021 | $ | 5,056 | |||||||||
Property and equipment, net consisted of the following, as of (in thousands, except depreciable life): | ||||||||||||
Life | December 31, | |||||||||||
(In years) | 2013 | 2012 | ||||||||||
Network and laboratory equipment | 3 – 5 | $ | 11,250 | $ | 10,654 | |||||||
Computer software and equipment | 2 – 3 | 3,928 | 3,747 | |||||||||
Furniture and fixtures | 3 – 7 | 176 | 176 | |||||||||
Office equipment | 3 – 5 | 137 | 106 | |||||||||
Leasehold improvements | 1 – 5 | 378 | 378 | |||||||||
Construction-in-progress | — | - | 236 | |||||||||
15,869 | 15,297 | |||||||||||
Accumulated depreciation and amortization | (12,870 | ) | (10,718 | ) | ||||||||
Property and equipment, net | $ | 2,999 | $ | 4,579 | ||||||||
Depreciation and amortization expense related to property and equipment was $2.2 million and $2.7 million for the years ended December 31, 2013 and 2012, respectively. | ||||||||||||
In addition to the property and equipment above, the Company has prepaid licenses. For the years ended December 31, 2013 and 2012, amortization related to these prepaid licenses was $660,000 and $388,000, respectively. | ||||||||||||
Inventories consisted of the following, as of (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Raw materials | $ | 2,103 | $ | 2,290 | ||||||||
Work in process | 780 | 687 | ||||||||||
Finished goods | 1,734 | 1,134 | ||||||||||
$ | 4,617 | $ | 4,111 | |||||||||
Other current liabilities consisted of the following, as of (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Amounts billed to the U.S. government in excess of approved rates | $ | 191 | $ | 191 | ||||||||
Warranty liability | 330 | 612 | ||||||||||
Customer deposits | 313 | 432 | ||||||||||
Capital lease obligation, current portion | 284 | 324 | ||||||||||
Restructuring liabilities | 30 | 168 | ||||||||||
Sales return reserve | 151 | 65 | ||||||||||
Other | 1,447 | 1,288 | ||||||||||
$ | 2,746 | $ | 3,080 |
FAIR_VALUE_MEASUREMENTS
FAIR VALUE MEASUREMENTS | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS [Abstract] | ' | ||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS | ' | ||||||||||||||||||||||||||||||||||||||||
NOTE 3—FAIR VALUE MEASUREMENTS | |||||||||||||||||||||||||||||||||||||||||
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements Using | |||||||||||||||||||||||||||||||||||||||||
Carrying Value | Quoted | Significant | Significant | ||||||||||||||||||||||||||||||||||||||
Prices in | Other | Unobservable | |||||||||||||||||||||||||||||||||||||||
Active | Observable | Inputs | |||||||||||||||||||||||||||||||||||||||
Markets for | Inputs | (Level 3) | |||||||||||||||||||||||||||||||||||||||
Identical | (Level 2) | ||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||
(Level 1) | |||||||||||||||||||||||||||||||||||||||||
December 31, 2013: | |||||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||||||||||
Money market funds | $ | 1,356 | $ | 1,356 | $ | - | $ | - | |||||||||||||||||||||||||||||||||
$ | 1,356 | $ | 1,356 | $ | - | $ | - | ||||||||||||||||||||||||||||||||||
Current liabilities: | |||||||||||||||||||||||||||||||||||||||||
Liability warrants | $ | 15 | $ | - | $ | - | $ | 15 | |||||||||||||||||||||||||||||||||
December 31, 2012: | |||||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||||||||||
Money market funds | $ | 2,856 | $ | 2,856 | $ | - | $ | - | |||||||||||||||||||||||||||||||||
$ | 2,856 | $ | 2,856 | $ | - | $ | - | ||||||||||||||||||||||||||||||||||
Current liabilities: | |||||||||||||||||||||||||||||||||||||||||
Liability warrants | $ | 24 | $ | - | $ | - | $ | 24 | |||||||||||||||||||||||||||||||||
The Company’s financial assets and liabilities are valued using market prices on active markets (“Level 1”), less active markets (“Level 2”) and unobservable markets (“Level 3”). Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from readily-available pricing sources for comparable instruments. Level 3 instruments are valued using unobservable market values in which there is little or no market data, and which require the Company to apply judgment to determine the fair value. | |||||||||||||||||||||||||||||||||||||||||
As of December 31, 2013 and 2012, the Company did not have any significant transfers of investments between Level 1, Level 2, and Level 3. | |||||||||||||||||||||||||||||||||||||||||
The amounts reported as cash and cash equivalents, accounts receivable, accounts payable, accrued compensation and other current liabilities approximate fair value due to their short-term maturities. The carrying value of the Company’s line of credit and capital lease obligations approximates fair value based upon borrowing rates currently available to the Company for loans and capital leases with similar terms. | |||||||||||||||||||||||||||||||||||||||||
Liability Warrants | |||||||||||||||||||||||||||||||||||||||||
The Company issued warrants to Bridge Bank in connection with a waiver of certain events of default that arose under a November 2009 loan and security agreement with Bridge Bank. Certain provisions in the warrant agreements provided for down-round protection if the Company raised equity capital at a per share price which was less than the per share price of the warrants. Such down-round protection also requires the Company to classify the value of the warrants as a liability on the issuance date and then record changes in the fair value through the consolidated statements of operations for each reporting period until the warrants are either exercised or cancelled. The fair value of the liability is recalculated and adjusted each quarter with the differences being charged to other income (expense), net on the consolidated statements of operations. The fair value of these warrants was determined using a Black-Scholes option-pricing model, which requires the use of significant unobservable market values. As a result, these warrants are classified as Level 3 financial instruments. On July 7, 2010, the Company raised additional equity through an offering of 2,760,000 shares at $1.75 per share, thus triggering the down-round protection and adjustment of the number of warrants issued to Bridge Bank. On December 24, 2013, the Company raised additional equity through an offering of 9,573,750 shares at $1.42 per share, thus triggering the down-round protection and adjustment of the number of warrants issued to Bridge Bank. | |||||||||||||||||||||||||||||||||||||||||
The fair value of the warrants was estimated using the following assumptions: | |||||||||||||||||||||||||||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
Stock price | $ | 1.53 | $ | 1.92 | |||||||||||||||||||||||||||||||||||||
Strike price | $ | 2.51 | $ | 3.32 | |||||||||||||||||||||||||||||||||||||
Expected life | 3.55 years | 4.55 years | |||||||||||||||||||||||||||||||||||||||
Risk-free interest rate | 1.3 | % | 0.62 | % | |||||||||||||||||||||||||||||||||||||
Volatility | 65 | % | 85 | % | |||||||||||||||||||||||||||||||||||||
Fair value per share | $ | 0.52 | $ | 1.03 | |||||||||||||||||||||||||||||||||||||
The following table summarizes the warrants subject to liability accounting as of December 31, 2013 and 2012 (in thousands, except share and per share amounts) (see also Note 6 – Stockholders’ Equity): | |||||||||||||||||||||||||||||||||||||||||
Year Ended December 31, 2013 | Year Ended December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
Holder | Original | Adjusted | Grant Date | Expiration Date | Price | Fair Value | Fair Value | Exercise of Warrants | Change in Fair Value | Exercise of Warrants | Change in Fair Value | Related | |||||||||||||||||||||||||||||
Warrants | Warrants | per | 31-Dec-13 | December 31, 2012 | Agreement | ||||||||||||||||||||||||||||||||||||
Share | |||||||||||||||||||||||||||||||||||||||||
Bridge Bank | 20,000 | 29,115 | 4/7/10 | 7/7/17 | $ | 2.51 | $ | 15 | $ | 24 | - | $ | (9 | ) | - | $ | 3 | Credit Agreement | |||||||||||||||||||||||
The change in the fair value of Level 3 liabilities is as follows (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Fair value at December 31, 2011 | $ | 21 | |||||||||||||||||||||||||||||||||||||||
Exercise of warrants | - | ||||||||||||||||||||||||||||||||||||||||
Change in fair value | 3 | ||||||||||||||||||||||||||||||||||||||||
Fair value at December 31, 2012 | 24 | ||||||||||||||||||||||||||||||||||||||||
Exercise of warrants | - | ||||||||||||||||||||||||||||||||||||||||
Change in fair value | (9 | ) | |||||||||||||||||||||||||||||||||||||||
Fair value at December 31, 2013 | $ | 15 | |||||||||||||||||||||||||||||||||||||||
The warrant liability is included in other current liabilities on the consolidated balance sheets. |
INTANGIBLE_ASSETS_AND_GOODWILL
INTANGIBLE ASSETS AND GOODWILL | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
INTANGIBLE ASSETS AND GOODWILL [Abstract] | ' | ||||||||||||||||||||||||
INTANGIBLE ASSETS AND GOODWILL | ' | ||||||||||||||||||||||||
NOTE 4—INTANGIBLE ASSETS AND GOODWILL | |||||||||||||||||||||||||
Intangible assets consist of the following (in thousands): | |||||||||||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | ||||||||||||||||||||||||
Gross | Accumulated | Net | Gross | Accumulated | Net | ||||||||||||||||||||
Amortization | Amortization | ||||||||||||||||||||||||
Customer relationships | $ | 3,277 | $ | (1,697 | ) | $ | 1,580 | $ | 3,277 | $ | (1,274 | ) | $ | 2,003 | |||||||||||
Existing technology | 3,783 | (2,473 | ) | 1,310 | 3,783 | (2,065 | ) | 1,718 | |||||||||||||||||
Order backlog | 732 | (732 | ) | - | 732 | (732 | ) | - | |||||||||||||||||
Patents | 457 | (397 | ) | 60 | 457 | (321 | ) | 136 | |||||||||||||||||
Trade name | 659 | (322 | ) | 337 | 659 | (246 | ) | 413 | |||||||||||||||||
Total | $ | 8,908 | $ | (5,621 | ) | $ | 3,287 | $ | 8,908 | $ | (4,638 | ) | $ | 4,270 | |||||||||||
During the year ended December 31, 2013 and 2012, amortization of intangible assets was as follows (in thousands): | |||||||||||||||||||||||||
31-Dec-13 | 31-Dec-12 | ||||||||||||||||||||||||
Cost of revenue | $ | 484 | $ | 489 | |||||||||||||||||||||
Selling, general and administrative expense | 499 | 522 | |||||||||||||||||||||||
$ | 983 | $ | 1,011 | ||||||||||||||||||||||
Estimated future amortization expense related to intangible assets as of December 31, 2013 is as follows (in thousands): | |||||||||||||||||||||||||
Years ending December 31, | |||||||||||||||||||||||||
2014 | $ | 893 | |||||||||||||||||||||||
2015 | 893 | ||||||||||||||||||||||||
2016 | 869 | ||||||||||||||||||||||||
2017 | 487 | ||||||||||||||||||||||||
2018 | 145 | ||||||||||||||||||||||||
Total | $ | 3,287 | |||||||||||||||||||||||
The Company performs a review of the carrying value of its intangible assets, if circumstances warrant. In its review, it compares the gross, undiscounted cash flows expected to be generated by the underlying assets against the carrying value of those assets. To the extent such cash flows do not exceed the carrying value of the underlying asset; it will record an impairment charge. During the fourth quarter of 2013, the Company performed an impairment analysis and did not find any indicators of impairment for its intangibles. | |||||||||||||||||||||||||
As of December 31, 2013, the Company had $9.9 million of goodwill in connection with the acquisitions of ChipX and Endwave. In addition to its annual review, the Company also performs a review of the carrying value of its intangible assets if the Company believes that indicators of impairment exist. During the fourth quarter of 2013, there were no factors which indicated impairment. The Company did not record impairment on any intangibles, including goodwill, for the year ended December 31, 2013. In addition, the Company did not record an impairment of goodwill for the year ended December 31, 2012. |
CREDIT_FACILITIES
CREDIT FACILITIES | 12 Months Ended | ||
Dec. 31, 2013 | |||
CREDIT FACILITIES [Abstract] | ' | ||
CREDIT FACILITIES | ' | ||
NOTE 5—CREDIT FACILITIES | |||
On March 25, 2013, the Company entered into a second amended and restated loan and security agreement (“Loan Agreement”) with Silicon Valley Bank (“SVB”) to replace the amended and restated loan and security agreement entered on December 9, 2011. Pursuant to the Loan Agreement, the total aggregate amount that the Company is entitled to borrow from SVB has increased to $7 million, which is now split into two different credit facilities, comprised of (i) the existing Revolving Loan facility which was amended to provide that the Company is entitled to borrow from SVB up to $3.5 million, based on net eligible accounts receivable after an 80% advance rate and subject to limits based on the Company’s eligible accounts as determined by SVB and (ii) a new facility under which the Company is entitled to borrow from SVB up to $3.5 million without reference to accounts receivable under which the principal balance and accrued interest must be repaid within 3 business days after the date of any advance under the facility. In addition, the Loan Agreement eliminates the financial covenants contained in the previous loan agreement. | |||
The Loan Agreement with SVB is secured by all of the Company’s assets, including all accounts, equipment, inventory, receivables, and general intangibles. The Loan Agreement contains certain restrictive covenants that will impose significant operating and financial restrictions on its operations, including, but not limited to restrictions that limit its ability to: | |||
· | Sell, lease, or otherwise transfer, or permit any of its subsidiaries to sell, lease or otherwise transfer, all or any part of its business or property, except in the ordinary course of business or in connection with certain indebtedness or investments permitted under the amended and restated loan agreement; | ||
· | Merge or consolidate, or permit any of its subsidiaries to merge or consolidate, with or into any other business organization, or acquire, or permit any of its subsidiaries to acquire, all or substantially all of the capital stock or property of another person; | ||
· | Create, incur, assume or be liable for any indebtedness, other than certain indebtedness permitted under the amended and restated loan and security agreement; | ||
· | Pay any dividends or make any distribution or payment on, or redeem, retire, or repurchase, any capital stock; and | ||
· | Make any investment, other than certain investments permitted under the amended and restated loan and security agreement. | ||
The Company had no outstanding balance on its line of credit as of December 31, 2013. |
STOCKHOLDERS_EQUITY
STOCKHOLDERS' EQUITY | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||
STOCKHOLDERS' EQUITY [Abstract] | ' | ||||||||||||||||||||||||||||||||
STOCKHOLDERS' EQUITY | ' | ||||||||||||||||||||||||||||||||
NOTE 6—STOCKHOLDERS’ EQUITY | |||||||||||||||||||||||||||||||||
Public Offering | |||||||||||||||||||||||||||||||||
On December 19, 2013, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Roth Capital Partners, LLC as representative of several underwriters to the Underwriting Agreement relating to a public offering of an aggregate of 8,325,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share at a public offering price of $1.42 per share. The Shares are accompanied by the associated rights to purchase shares of Series A Junior Preferred Stock, par value $0.001 per share, of the Company created by the Rights Agreement, dated December 16, 2011, between the Company and the American Stock Transfer & Trust Company, LLC, as Rights Agent (the “Rights Agreement”). Under the terms of the Underwriting Agreement, the Company granted the Underwriters a 30 day option to purchase up to an additional 1,248,750 shares of common stock to cover over-allotments. | |||||||||||||||||||||||||||||||||
On December 24, 2013, the Company completed its public offering of 9,573,750 newly issued shares of common stock at a price to the public of $1.42 per share. The number of shares sold in the offering included the underwriter’s full exercise on December 24, 2013 of their over-allotment option of 1,248,750 shares of common stock. The net proceeds to the Company from the offering was approximately $12.3 million which consisted of $12.5 million after underwriting discounts, commissions and expenses less an additional $250,000 for legal, accounting, registration and other transaction costs related to the public offering. | |||||||||||||||||||||||||||||||||
Modified Dutch Auction Tender Offer | |||||||||||||||||||||||||||||||||
On March 23, 2012, the Company announced the commencement of a modified Dutch auction tender offer to purchase up to $2.0 million in value of the Company’s common stock, $0.001 par value per share, at a price not greater than $3.10 nor less than $2.85 per share. | |||||||||||||||||||||||||||||||||
On May 22, 2012, the Company completed its modified Dutch auction tender offer and repurchased 701,754 shares of its common stock, at a price of $2.85 per share and at a total cost of $2.2 million, which included $209,000 for investment banking, registration and other transaction costs. The repurchased shares are included as treasury shares in the consolidated balance sheet as of December 31, 2013. | |||||||||||||||||||||||||||||||||
Common and Preferred Stock | |||||||||||||||||||||||||||||||||
In December 2008, the Company’s stockholders approved an amendment to the Certificate of Incorporation to authorize 50,000,000 shares of common stock of par value $0.001. In addition, the Company is authorized to issue 1,000,000 shares of preferred stock of $0.001 par value of which 300,000 shares have been designated Series A Junior Preferred Stock with powers, preferences and rights as set forth in the certificate of designation dated December 16, 2011; the remainder of the shares of preferred stock are undesignated, for which the Board of Directors is authorized to fix the designation, powers, preferences and rights. As of December 31, 2013 and 2012, there were no shares of preferred stock issued or outstanding. | |||||||||||||||||||||||||||||||||
On December 16, 2011 (the “Adoption Date”), the Company adopted a Rights Agreement that may have the effect of deterring, delaying, or preventing a change in control. Under the rights plan, the Company issued a dividend of one preferred share purchase right for each share of common stock held by stockholders of record as of January 6, 2012, and the Company will issue one preferred stock purchase right to each share of common stock issued between January 6, 2012 and the earlier of either the rights’ exercisability or the expiration of the Rights Agreement. Each right entitles stockholders to purchase one one-thousandth of the Company’s Series A Junior Preferred Stock. | |||||||||||||||||||||||||||||||||
In general, the exercisability of the rights to purchase preferred stock will be triggered if any person or group, including persons knowingly acting in concert to affect the control of the Company, is or becomes a beneficial owner of 10% or more of the outstanding shares of the Company’s common stock after the Adoption Date. Stockholders or beneficial ownership groups who owned 10% or more of the outstanding shares of common stock of the Company on or before the Adoption Date will not trigger the preferred share purchase rights unless they acquire an additional 1% or more of the outstanding shares of the Company’s common stock. Each right entitles a holder with the right upon exercise to purchase one one-thousandth of a share of preferred stock at an exercise price that is currently set at $8.50 per right, subject to purchase price adjustments as set forth in the rights agreement. Each share of preferred stock has voting rights equal to one thousand shares of common stock. In the event that exercisability of the rights is triggered, each right held by an acquiring person or group would become void. As a result, upon triggering of exercisability of the rights, there would be significant dilution in the ownership interest of the acquiring person or group, making it difficult or unattractive for the acquiring person or group to pursue an acquisition of the Company. These rights expire in December of 2014, unless earlier redeemed or exchanged by the Company. | |||||||||||||||||||||||||||||||||
During the third quarter of fiscal 2010 the Company raised equity by selling an additional 2,760,000 shares to the public at a per share price of $1.75 resulting in gross proceeds of $4.8 million. During the fourth quarter of fiscal 2013 the Company raised equity by selling an additional 9,573,750 shares to the public at a per share price of $1.42 resulting in gross proceeds of $13.6 million. During the 2010 and 2013 stock offerings, the Company issued additional warrants to purchase common stock due to the anti-dilution provisions for the warrants that had been previously issued. For the 20,000 warrants originally issued to Bridge Bank, due to the anti-dilution provision, an additional 2,671 warrants were issued as a result of the 2010 stock offering for a total of 22,671 warrants with an average exercise price of $3.22. For the 22,671 warrants issued to Bridge Bank, due to the anti-dilution provision, an additional 6,444 warrants were issued as a result of the 2013 stock offering for a total of 29,115 warrants with an average exercise price of $2.51. As of December 31, 2013 and 2012, the 29,115 and 22,671, respectively, warrants were still outstanding. | |||||||||||||||||||||||||||||||||
Warrants | |||||||||||||||||||||||||||||||||
As of December 31, 2013, the Company had a total of 1,468,239 warrants to purchase common stock outstanding under all warrant arrangements. During the year ended December 31, 2012, 137,500 warrants were exercised that resulted in the issuance of 14,158 shares of common stock. There were no warrants exercised during the year ended December 31, 2013. During the year ended December 31, 2013, 348,800 warrants expired. There were no warrants that expired during the year ended December 31, 2012. Many of the warrants have anti-dilution provisions which adjust the number of warrants available to the holder such as, but not limited to, stock dividends, stock splits, and certain reclassifications, exchanges, combinations or substitutions. These provisions are specific to each warrant agreement. | |||||||||||||||||||||||||||||||||
Warrants Outstanding as of | Warrants Expired | Warrants Exercised | |||||||||||||||||||||||||||||||
December 31, | During the Year Ended | During the Year Ended | |||||||||||||||||||||||||||||||
December 31, | December 31, | ||||||||||||||||||||||||||||||||
Holder | Exercise Price | Expiration | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||||||||||
per Share | Date | ||||||||||||||||||||||||||||||||
Alliance Advisors LLC | $ | 1.75 | 7/20/14 | 25,000 | 25,000 | - | - | ||||||||||||||||||||||||||
Bridge Bank | $ | 2.51 | 7/7/17 | 29,115 | 22,671 | - | - | ||||||||||||||||||||||||||
Warrants issued to PIPE investros | $ | 2.5 | 12/28/13 | - | 242,500 | 242,500 | 137,500 | ||||||||||||||||||||||||||
Sandgrain Securities Inc. | $ | 2.5 | 12/28/13 | - | 4,000 | 4,000 | - | ||||||||||||||||||||||||||
Warrants issued to investors in connection with the Lumera Merger | $ | 24 | 2/21/13 | - | 22,500 | 22,500 | - | ||||||||||||||||||||||||||
Warrants issued to investors in connection with the Lumera Merger | $ | 6.08 | 1/16/14 | 284,999 | 284,999 | - | - | ||||||||||||||||||||||||||
Silicon Valley Bank | $ | 0.73 | 10/5/17 | 4,125 | 4,125 | - | - | ||||||||||||||||||||||||||
Silicon Valley Bank | $ | 4 | 4/23/17 | 125,000 | 125,000 | - | - | ||||||||||||||||||||||||||
Warrants issued to GigOptix LLC executives in connection with the Lumera Merger | $ | 6.08 | 7/16/13 | - | 79,800 | 79,800 | - | ||||||||||||||||||||||||||
DBSI Liquidating Trust | $ | 2.6 | 4/8/14 | 500,000 | 500,000 | - | - | ||||||||||||||||||||||||||
DBSI Liquidating Trust | $ | 3 | 4/8/15 | 500,000 | 500,000 | - | - | ||||||||||||||||||||||||||
1,468,239 | 1,810,595 | 348,800 | 137,500 | ||||||||||||||||||||||||||||||
Equity Incentive Plan | |||||||||||||||||||||||||||||||||
As of December 31, 2013 and 2012, there were 10,306,671 options and 10,100,429 options outstanding under all stock option plans. As of December 31, 2013 and 2012, there were 1,313,801 and 199,005 RSUs outstanding under the 2008 Equity Incentive Plan. | |||||||||||||||||||||||||||||||||
2008 Equity Incentive Plan | |||||||||||||||||||||||||||||||||
In December 2008, the Company adopted the 2008 Equity Incentive Plan (the “2008 Plan”) for directors, employees, consultants and advisors to the Company or its affiliates. Under the 2008 Plan, 2,500,000 shares of common stock were reserved for issuance upon the completion of a merger with Lumera Corporation (“Lumera”) on December 9, 2008. On January 1 of each year, starting in 2009, the aggregate number of shares reserved for issuance under the 2008 Plan increase automatically by the lesser of (i) 5% of the number of shares of common stock outstanding as of the Company’s immediately preceding fiscal year, or (ii) a number of shares determined by the Board of Directors. The maximum number of shares of common stock to be granted is up to 21,000,000 shares. Forfeited options or awards generally become available for future awards. As of December 31, 2013, the stockholders had approved 15,021,253 shares for future issuance. On January 1, 2013, there was an automatic increase of 1,110,288 shares. As of December 31, 2013, 11,130,371 options to purchase common stock and RSUs were outstanding and 2,784,883 shares are authorized for future issuance under the 2008 equity incentive plan. | |||||||||||||||||||||||||||||||||
Under the 2008 Plan, the exercise price of a stock option is at least 100% of the stock’s fair market value on the date of grant, and if an ISO is granted to a 10% stockholder at least 110% of the stock’s fair market value on the date of grant. Vesting periods for awards are recommended by the chief executive officer and generally provide for stock options to vest over a four-year period, with a one year vesting cliff of 25%, and have a maximum life of ten years from the date of grant. The Company has also issued RSUs which generally vest over a one to four year period. | |||||||||||||||||||||||||||||||||
2007 Equity Incentive Plan | |||||||||||||||||||||||||||||||||
In August 2007, GigOptix LLC adopted the GigOptix LLC Equity Incentive Plan (the "2007 Plan"). The 2007 Plan provided for grants of options to purchase membership units, membership awards and restricted membership units to employees, officers and non-employee directors, and upon the completion of the merger with Lumera were converted into grants of up to 632,500 shares of stock. Vesting periods are determined by the Board of Directors and generally provide for stock options to vest over a four-year period and expire ten years from date of grant. Vesting for certain shares of restricted stock is contingent upon both service and performance criteria. The 2007 Plan was terminated upon the completion of merger with Lumera on December 9, 2008 and the remaining 864 stock options not granted under the 2007 Plan were cancelled. No shares of the Company’s common stock remain available for issuance of new grants under the 2007 Plan other than for satisfying exercises of stock options granted under this plan prior to its termination. As of December 31, 2013, options to purchase a total of 414,936 shares of common stock and 4,125 warrants to purchase common stock were outstanding. | |||||||||||||||||||||||||||||||||
Lumera 2000 and 2004 Stock Option Plan | |||||||||||||||||||||||||||||||||
In December 2008, in connection with the merger with Lumera, the Company assumed the existing Lumera 2000 Equity Incentive Plan and the Lumera 2004 Stock Option Plan (the “Lumera Plan”). All unvested options granted under the Lumera Plan were assumed by the Company as part of the merger. All contractual terms of the assumed options remain the same, except for the converted number of shares and exercise price based on merger conversion ratio of 0.125. As of December 31, 2013, no additional options can be granted under the Lumera Plan, and options to purchase a total of 75,165 shares of common stock were outstanding. | |||||||||||||||||||||||||||||||||
Stock-based Compensation Expense | |||||||||||||||||||||||||||||||||
The following table summarizes the Company’s stock-based compensation expense for fiscal years 2013 and 2012 (in thousands): | |||||||||||||||||||||||||||||||||
Years ended December 31, | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Cost of revenue | $ | 263 | $ | 230 | |||||||||||||||||||||||||||||
Research and development expense | 1,034 | 1,579 | |||||||||||||||||||||||||||||||
Selling, general and administrative expense | 2,257 | 3,146 | |||||||||||||||||||||||||||||||
Restructuring expense | 662 | 132 | |||||||||||||||||||||||||||||||
$ | 4,216 | $ | 5,087 | ||||||||||||||||||||||||||||||
As of December 31, 2013, included in the $4.2 million of stock-based compensation expense is $662,000 in restructuring expense to accelerate the vesting of stock options (see Note 8 - Restructuring). | |||||||||||||||||||||||||||||||||
During the years ended December 31, 2013 and 2012, the Company granted options to purchase 689,010 and 2,771,533 shares of common stock, respectively, with an estimated total grant-date fair value of $436,000 and $4.8 million, respectively and $0.63 and $1.74 per share, respectively. | |||||||||||||||||||||||||||||||||
During the year ended December 31, 2013, the Company granted 1,578,373 RSUs with a grant-date fair value of $1.8 million or $1.16 per share. During the year ended December 31, 2012, the Company granted 829,269 RSUs with a grant-date fair value of $2.3 million or $2.78 per share. | |||||||||||||||||||||||||||||||||
As of December 31, 2013, the total compensation cost not yet recognized in connection with unvested stock options and RSUs under the Company’s equity compensation plans was approximately $3.9 million and $1.3 million, respectively. Unrecognized compensation will be amortized on a straight-line basis over a weighted-average period of approximately 2.07 years for stock options and approximately 1.85 years for RSUs. | |||||||||||||||||||||||||||||||||
The Company generally estimates the fair value of stock options granted using a Black-Scholes option-pricing model. This model requires the input of highly subjective assumptions, including the options expected life and the price volatility of the Company’s underlying stock. Actual volatility, expected lives, interest rates and forfeitures may be different from the Company’s assumptions, which would result in an actual value of the options being different from estimated. This fair value of stock option grants is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting period. | |||||||||||||||||||||||||||||||||
The majority of the stock options that the Company grants to its employees provide for vesting over a specified period of time, normally a four-year period, with no other conditions to vesting. However, the Company may also grant stock options for which vesting occurs not only on the basis of elapsed time, but also on the basis of specified company performance criteria being satisfied. In this case, the Company makes a determination regarding the probability of the performance criteria being achieved and uses a Black-Scholes option-pricing model to value the options incorporating management’s assumptions for the expected holding period, risk-free interest rate, stock price volatility and dividend yield. Compensation expense is recognized ratably over the vesting period, if it is expected that the performance criteria will be met. | |||||||||||||||||||||||||||||||||
The fair value of the Company’s stock options granted to employees was estimated using the following weighted-average assumptions: | |||||||||||||||||||||||||||||||||
Expected Term—Expected term used in the Black-Scholes option-pricing model represents the period that the Company’s stock options are expected to be outstanding and is measured using the technique described in Staff Accounting Bulletin No. 107. | |||||||||||||||||||||||||||||||||
Expected Volatility—Expected volatility used in the Black-Scholes option-pricing model is derived from a combination of historical and implied volatility of guideline companies selected based on similar industry and product focus. Forfeitures are estimated at the time of grant and are revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. | |||||||||||||||||||||||||||||||||
Expected Dividend—The Company has never paid dividends and currently does not intend to do so, and accordingly, the dividend yield percentage is zero for all periods. | |||||||||||||||||||||||||||||||||
Risk-Free Interest Rate—The Company bases the risk-free interest rate used in the Black-Scholes valuation method on the implied yield currently available on U.S. Treasury constant maturities issued with a term equivalent to the expected term of the option. | |||||||||||||||||||||||||||||||||
Stock Option and RSU Activity | |||||||||||||||||||||||||||||||||
The following is a summary of option activity for the Company’s equity incentive plans, including both the 2008 Plan and other prior plans for which there are outstanding options but no new grants since the 2008 Plan was adopted: | |||||||||||||||||||||||||||||||||
Years Ended December 31, | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Options | Weighted-average | Weighted-average | Aggregate | Options | Weighted- | Weighted-average | Aggregate | ||||||||||||||||||||||||||
Exercise Price | Remaining | Intrinsic | average | Remaining | Intrinsic | ||||||||||||||||||||||||||||
Contractual Term, | Value, in Thousands | Exercise Price | Contractual Term, | Value, in | |||||||||||||||||||||||||||||
in Years | in Years | Thousands | |||||||||||||||||||||||||||||||
Outstanding, beginning of year | 10,100,429 | $ | 2.42 | 8,495,725 | $ | 2.58 | |||||||||||||||||||||||||||
Granted | 689,010 | $ | 0.92 | 2,771,533 | $ | 2.64 | |||||||||||||||||||||||||||
Exercised | (12,221 | ) | $ | 1.09 | $ | 3 | (230,466 | ) | $ | 1.73 | $ | 178 | |||||||||||||||||||||
Forfeited/Expired | (470,547 | ) | $ | 2.12 | (936,363 | ) | $ | 4.65 | |||||||||||||||||||||||||
Balance, end of year | 10,306,671 | $ | 2.34 | 6.96 | $ | 1,405 | 10,100,429 | $ | 2.42 | 7.81 | $ | 1,874 | |||||||||||||||||||||
Vested and exercisable and expected to vest, end of year | 10,101,382 | $ | 2.34 | 6.93 | $ | 1,379 | 9,512,994 | $ | 2.43 | 7.77 | $ | 1,868 | |||||||||||||||||||||
Vested and exercisable, end of year | 7,297,096 | $ | 2.39 | 6.47 | $ | 1,017 | 5,004,706 | $ | 2.32 | 6.92 | $ | 1,809 | |||||||||||||||||||||
The aggregate intrinsic value reflects the difference between the exercise price of the underlying stock options and the Company’s closing share price of $1.53 as of December 31, 2013. | |||||||||||||||||||||||||||||||||
The following table summarizes information about options outstanding and exercisable under the Company’s equity incentive plans as of December 31, 2013: | |||||||||||||||||||||||||||||||||
Options Outstanding | Options Exercisable | ||||||||||||||||||||||||||||||||
Number of Shares | Weighted- | Weighted- | Exercisable | Weighted- | |||||||||||||||||||||||||||||
Outstanding | average | average | average | ||||||||||||||||||||||||||||||
Remaining | Exercise | Exercise Price | |||||||||||||||||||||||||||||||
Contractual Life, | Price | ||||||||||||||||||||||||||||||||
in Years | |||||||||||||||||||||||||||||||||
$ | 0.73 – $1.83 | 2,836,418 | 6.03 | $ | 1.04 | 2,075,768 | $ | 1.05 | |||||||||||||||||||||||||
$ | 1.86 – $2.40 | 2,044,982 | 6.6 | $ | 2.15 | 1,780,182 | $ | 2.14 | |||||||||||||||||||||||||
$ | 2.50 – $2.70 | 5,055,034 | 7.73 | $ | 2.63 | 3,083,900 | $ | 2.62 | |||||||||||||||||||||||||
$ | 3.03 – $18.16 | 308,759 | 6.02 | $ | 4.11 | 295,768 | $ | 4.16 | |||||||||||||||||||||||||
$ | 18.18 – $57.44 | 61,478 | 2.67 | $ | 35.61 | 61,478 | $ | 35.61 | |||||||||||||||||||||||||
$ | 0.73 – $57.44 | 10,306,671 | 6.96 | $ | 2.34 | 7,297,096 | $ | 2.39 | |||||||||||||||||||||||||
RSUs are converted into shares of the Company’s common stock upon vesting on a one-for-one basis. Typically, vesting of RSUs is subject to the employee’s continuing service to the Company. RSUs generally vest over a period of one to four years and are expensed ratably on a straight line basis over their respective vesting period net of estimated forfeitures. The fair value of the RSUs granted is the product of the number of shares granted and the grant date fair value of the Company’s common stock. | |||||||||||||||||||||||||||||||||
The following is a summary of RSU activity for the indicated periods: | |||||||||||||||||||||||||||||||||
Years Ended December 31, | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Number of | Weighted- | Weighted- | Aggregate | Number of | Weighted- | Weighted- | Aggregate | ||||||||||||||||||||||||||
Shares | Average Grant | average | Intrinsic | Shares | Average Grant | average | Intrinsic | ||||||||||||||||||||||||||
Date Fair | Remaining | Value, in | Date Fair | Remaining | Value, in | ||||||||||||||||||||||||||||
Value | Contractual | Thousands | Value | Contractual | Thousands | ||||||||||||||||||||||||||||
Term, in Years | Term, in Years | ||||||||||||||||||||||||||||||||
Outstanding, January 1 | 199,005 | $ | 2.78 | 0.16 | $ | 382 | - | $ | - | ||||||||||||||||||||||||
Granted | 1,578,373 | 1.16 | 829,269 | 2.78 | |||||||||||||||||||||||||||||
Released | (426,141 | ) | 1.83 | (607,206 | ) | 2.78 | |||||||||||||||||||||||||||
Forfeited/expired | (37,436 | ) | 1.19 | (23,058 | ) | 2.75 | |||||||||||||||||||||||||||
Outstanding, December 31 | 1,313,801 | $ | 1.19 | 1.85 | $ | 2,010 | 199,005 | $ | 2.78 | 0.16 | $ | 382 | |||||||||||||||||||||
The majority of the RSUs that vested in the year ended December 31, 2013 were net-share settled such that the Company withheld shares with value equivalent to the employees’ minimum statutory obligation for the applicable income and other employment taxes, and remitted the cash to the appropriate taxing authorities. The total shares withheld were based on the value of the RSUs on their vesting date as determined by the Company’s closing stock price. These net-share settlements had the effect of share repurchases by the Company as they reduced and retired the number of shares that would have otherwise been issued as a result of the vesting and did not represent an expense to the Company. For the year ended December 31, 2013, 426,141 shares of RSUs vested with an intrinsic value of approximately $652,000. The Company withheld 150,242 shares to satisfy approximately $194,000 of employees’ minimum tax obligation on the vested RSUs. |
BENEFIT_PLANS
BENEFIT PLANS | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
BENEFIT PLANS [Abstract] | ' | ||||||||
BENEFIT PLANS | ' | ||||||||
NOTE 7—BENEFIT PLANS | |||||||||
In connection with the Company’s Swiss subsidiary, the Company maintains a pension plan covering minimum requirements according to Swiss law. It has set up the occupational benefits by means of an affiliation to a collective foundation, the Swisscanto Collective Foundation. | |||||||||
Funding Policy | |||||||||
The Company’s practice is to fund the pension plan in an amount at least sufficient to meet the minimum requirements of Swiss law. | |||||||||
Benefit Obligations and Plan Assets | |||||||||
The following tables summarize changes in the benefit obligation, the plan assets and the funded status of the pension benefit plan as well as the components of net periodic benefit costs, including key assumptions (in thousands). | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Change in projected benefit obligation: | |||||||||
Beginning benefit obligation | $ | 692 | $ | 450 | |||||
Service cost | 35 | 35 | |||||||
Interest cost | 16 | 10 | |||||||
Plan participants contributions | 21 | 14 | |||||||
Foreign exchange adjustments | 16 | 19 | |||||||
Actuarial loss (gain) | (132 | ) | 77 | ||||||
Transfer in | - | 87 | |||||||
Ending benefit obligation | $ | 648 | $ | 692 | |||||
Change in plan assets: | |||||||||
Beginning fair value of plan assets | $ | 440 | $ | 385 | |||||
Employer contributions | 21 | 14 | |||||||
Plan participants' contributions | 21 | 14 | |||||||
Foreign exchange adjustments | 14 | 12 | |||||||
Expected return on plan assets | 12 | (72 | ) | ||||||
Transfer in | - | 87 | |||||||
Ending fair value of plan assets | $ | 508 | $ | 440 | |||||
Benefits paid | $ | - | $ | - | |||||
The following table summarizes the funding status as of December 31, 2013 and 2012 (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Projected benefit obligation | $ | (648 | ) | $ | (692 | ) | |||
Fair value of plan assets | 508 | 440 | |||||||
Funded status of the plan at the end of the year, recorded as a long-term liability | $ | (140 | ) | $ | (252 | ) | |||
The total net periodic benefit cost for the year ending December 31, 2014 is expected to be approximately $23,000. | |||||||||
The amount that will be amortized from accumulated other comprehensive income, net of tax, into net periodic benefit cost in 2014 is $10,000. The following are the components of estimated net periodic benefit cost in 2014 (in thousands): | |||||||||
Year ending | |||||||||
December 31, | |||||||||
2014 | |||||||||
Service cost (net) | $ | 30 | |||||||
Interest cost | 14 | ||||||||
Expected return on plan assets | (11 | ) | |||||||
Amortization: | |||||||||
Actuarial gain | (10 | ) | |||||||
Net periodic benefit cost | $ | 23 | |||||||
Assumptions | |||||||||
Weighted average assumptions used to determine benefit obligations as of December 31, 2013 for the plan were a discount rate of 2.25%, a rate of compensation increase of 2.00%, and an expected return on assets of 2.25%. The GigOptix-Helix Plan is reinsured with the Helvetia Swiss Life Insurance Company via the Swisscanto Collective Foundation. The expected return on assets is derived as follows: Swiss pension law requires that the insurance company pay an interest rate of at least 1.5% per annum on old-age savings accounts. In addition to the mandatory rate, the Company expects 0.75% of surplus sharing from the insurance company. | |||||||||
Weighted average assumptions used to determine costs for the plan as of December 31, 2012 were a discount rate of 1.90%, rate of compensation increase of 2.00%, and expected return on assets of 1.90%. | |||||||||
Net Periodic Benefit Cost | |||||||||
The net periodic benefit cost for the plan included the following components (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Service cost (net) | $ | 35 | $ | 35 | |||||
Interest cost | 16 | 10 | |||||||
Net periodic benefit cost | $ | 51 | $ | 45 | |||||
Plan Assets | |||||||||
The benefits are fully insured. There are no retirees and the plan assets are equal to the sum of the old-age savings and of various other accounts within the affiliation contract. | |||||||||
The allocation of the assets of the plan at the measurement dates were in cash, bonds, stocks, mutual funds, hedge funds, and commodities. The Company is required by Swiss law to contribute to retirement funds for the employees of its Swiss subsidiary. Funds are managed by third parties according to statutory guidelines. Cash equivalents may be valued using quoted prices in markets that are not active, resulting in a Level 2 fair value measurement within the hierarchy set forth in the accounting guidance for fair value measurements. | |||||||||
Contributions | |||||||||
The Company anticipates contributions to the plan of approximately $22,000 in the year ending December 31, 2014. Actual contributions may differ from expected contributions due to various factors, including performance of plan assets, interest rates and potential legislative changes. The Company is not able to estimate expected contributions beyond fiscal year 2014. | |||||||||
Estimated Future Benefit Payments | |||||||||
The Company does not expect benefit payments through 2024. | |||||||||
Israel Severance Plan liability | |||||||||
Under Israeli law, the Company is required to make severance payments to its retired or dismissed Israeli employees and Israeli employees leaving its employment in certain other circumstances. The Company’s severance pay liability to its Israeli employees is calculated based on the salary of each employee multiplied by the number of years of such employee’s employment and is presented in its balance sheet in long-term liabilities, as if it was payable at each balance sheet date on an undiscounted basis. This liability is partially funded by the purchase of insurance policies in the name of the employees. The surrender value of the insurance policies of $9,000 is presented in long-term assets. Severance pay expense for the year ended December 31, 2013 was $0. As of December 31, 2013, accrued severance liability and severance assets were $15,000 and $9,000, respectively. | |||||||||
GigOptix 401(k) Plan | |||||||||
The Company has a 401(k) retirement plan which was adopted by GigOptix, LLC as of January 4, 2008. In December 2011, the GigOptix 401k plan merged into the Endwave 401k plan. This plan is intended to be a qualified retirement plan under the Internal Revenue Code. It is a defined contribution as opposed to a defined benefit plan. The Company made $59,000 and $28,000 matching contributions during fiscal 2013 and 2012, respectively. |
RESTRUCTURING
RESTRUCTURING | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
RESTRUCTURING [Abstract] | ' | ||||||||
RESTRUCTURING | ' | ||||||||
NOTE 8—RESTRUCTURING | |||||||||
During the first quarter of 2013, the Company undertook restructuring activities to reduce its expenses. The components of the restructuring charge included $662,000 of non-cash expenses associated with the acceleration of stock options and RSUs, $288,000 of cash expenses for severance, benefits and payroll taxes and other costs associated with employee terminations. The net charge for these restructuring activities was $950,000. | |||||||||
During the first of quarter of 2012, the Company undertook restructuring activities to reduce its expenses. The components of the restructuring charge included severance, benefits, payroll taxes, expenses associated with the acceleration of stock options, and other costs associated with employee terminations. The net charge for these restructuring activities was $207,000. | |||||||||
For the year ended December 31, 2012, the Company recorded restructuring expense of $93,000 that was the result of a $207,000 restructuring charge mentioned above which was partially offset by a $74,000 benefit related to the sublet of the Palo Alto facility and a $40,000 benefit due to lower than anticipated restructuring charges related to the Endwave merger. | |||||||||
The following is a summary of the restructuring activity (in thousands): | |||||||||
Year ending December 31, | |||||||||
2013 | 2012 | ||||||||
Beginning balance | $ | 168 | $ | 696 | |||||
Charges | 950 | 207 | |||||||
Uses and adjustments | (1,088 | ) | (735 | ) | |||||
Ending balance | $ | 30 | $ | 168 | |||||
As of December 31, 2013, the $30,000, respectively, in accrued restructuring, which is included in other current liabilities, represented the deposit for the Palo Alto facilities restructuring which is expected to be paid out by the first quarter of 2014. | |||||||||
As of December 31, 2012, the Company had $168,000, respectively, in accrued restructuring, which was all included in other current liabilities. |
INCOME_TAXES
INCOME TAXES | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
INCOME TAXES [Abstract] | ' | ||||||||
INCOME TAXES | ' | ||||||||
NOTE 9—INCOME TAXES | |||||||||
The components of loss before provision for income taxes are as follows (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
United States | $ | 1,480 | $ | (6,156 | ) | ||||
International | (3,376 | ) | (767 | ) | |||||
Loss before provision for income taxes | $ | (1,896 | ) | $ | (6,923 | ) | |||
Components of provision for income taxes are as follows (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Current | |||||||||
United States | $ | 37 | $ | 115 | |||||
International | - | - | |||||||
State | 13 | 2 | |||||||
Total | 50 | 117 | |||||||
Deferred | |||||||||
United States | - | (36 | ) | ||||||
International | - | - | |||||||
Total | - | (36 | ) | ||||||
Provision for income taxes | $ | 50 | $ | 81 | |||||
Provision for income taxes differs from the amount computed by applying the statutory United States federal income tax rate to loss before taxes as follows: | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Income tax at the federal statutory rate | (34.00 | )% | (34.00 | )% | |||||
State tax net of federal benefit | 0.71 | % | 0.02 | % | |||||
Foreign tax rate differential | 60.55 | % | 4.19 | % | |||||
Permanent items and other | 1.93 | % | 1.67 | % | |||||
Losses not benefited | (26.55 | )% | 29.29 | % | |||||
Effective tax rate | 2.64 | % | 1.17 | % | |||||
The components of the net deferred tax assets and liabilities are as follows (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Deferred tax asset (liability), net | |||||||||
Net operating losses | $ | 20,398 | $ | 21,530 | |||||
Tax credits | 3,022 | 3,022 | |||||||
Accrued and reserves | 1,872 | 2,139 | |||||||
Fixed assets | 966 | 847 | |||||||
Other | 2,176 | 1,506 | |||||||
Total deferred tax asset | 28,434 | 29,044 | |||||||
Valuation allowance | (27,587 | ) | (27,898 | ) | |||||
Net deferred tax asset | 847 | 1,146 | |||||||
Pension other comprehensive income | (40 | ) | - | ||||||
Intangible assets | (847 | ) | (1,146 | ) | |||||
Deferred tax liability | (887 | ) | (1,146 | ) | |||||
Net deferred tax asset (liability) | $ | (40 | ) | $ | - | ||||
The deferred tax liability is included in other long term liabilities on the consolidated balance sheet. | |||||||||
The Company has a full valuation allowance on deferred tax assets in excess of deferred tax liabilities. Because of its limited operating history and cumulative losses, management believes it is more likely than not that the remaining deferred tax assets will not be realized. | |||||||||
The Company’s valuation allowance decreased by approximately $311,000 during the year ended December 31, 2013 and decreased by approximately $1.4 million during the year ended December 31, 2012. | |||||||||
The Company has approximately $42.9 million of federal net operating losses carryforwards and $27.2 million of state net operating loss carryforwards as of December 31, 2013. The federal and state net operating losses expire starting in 2014 through year 2033. The Company has approximately $3.8 million of federal research and development tax credit (“R&D credit”) carryforwards and $3.4 million of California R&D credit carryforwards as of December 31, 2013. The federal R&D credit carryforwards begin to expire in 2029 while the California R&D credits are not subject to a carryforward limitation. Utilization of a portion of the net operating losses and credit carryforwards are subject to an annual limitation due to the ownership change provision of the Internal Revenue Code of 1986, as amended and similar state provisions. The annual limitation may result in the expiration of net operating losses and credits before utilization. The Company also has approximately $13.6 million of net operating loss carryforwards in Israel related to its acquisition of ChipX which can be carried forward indefinitely. | |||||||||
Any interest and penalties incurred on the settlement of outstanding tax positions would be recorded as a component of income tax expense. The Company recorded $11,000 and $9,000 of interest and penalty expenses as of December 31, 2013 and 2012, respectively. | |||||||||
The Company’s unrecognized tax benefits as of December 31, 2013 relate to various domestic and foreign jurisdictions. As of December 31, 2013, the Company had total gross unrecognized tax benefits of $2.8 million, which if recognized would affect the effective tax rate. As of December 31, 2013 and 2012, the amount of long-term income taxes payable for unrecognized tax benefits, including accrued interest, was $368,000 and $331,000, respectively. The Company does not anticipate any significant changes to its unrecognized tax benefits within the next 12 months. | |||||||||
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands): | |||||||||
Total | |||||||||
Balance at December 31, 2011 | $ | 2,065 | |||||||
Increases related to current year tax positions | 364 | ||||||||
Increases related to prior year tax positions | 99 | ||||||||
Decreases related to prior year tax positions | (5 | ) | |||||||
Balance at December 31, 2012 | 2,523 | ||||||||
Increases related to current year tax positions | 205 | ||||||||
Increases related to prior year tax positions | 37 | ||||||||
Decreases related to prior year tax positions | - | ||||||||
Balance at December 31, 2013 | $ | 2,765 | |||||||
The Company files tax returns as prescribed by the tax laws of the jurisdictions it operates which include U.S. federal, U.S. state and foreign tax returns. The Company’s major tax jurisdictions are the U.S., California, Switzerland, Germany and Israel. The Company’s federal and state tax returns for the years 2000 through 2013 remain subject to examination. |
NET_LOSS_PER_SHARE
NET LOSS PER SHARE | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
NET LOSS PER SHARE [Abstract] | ' | ||||||||
NET LOSS PER SHARE | ' | ||||||||
NOTE 10—NET LOSS PER SHARE | |||||||||
The following table summarizes total securities outstanding which were not included in the calculation of diluted net loss per share because to do so would have been anti-dilutive: | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Stock options and restricted stock units | 11,620,472 | 10,299,434 | |||||||
Common stock warrants | 1,468,239 | 1,810,595 | |||||||
Total | 13,088,711 | 12,110,029 |
SEGMENT_AND_GEOGRAPHIC_INFORMA
SEGMENT AND GEOGRAPHIC INFORMATION | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
SEGMENT AND GEOGRAPHIC INFORMATION [Abstract] | ' | ||||||||
SEGMENT AND GEOGRAPHIC INFORMATION | ' | ||||||||
NOTE 11—SEGMENT AND GEOGRAPHIC INFORMATION | |||||||||
The Company has determined that it operates as a single operating and reportable segment. The following tables reflect the results of the Company’s reportable segment consistent with the management system used by the Company’s Chief Executive Officer, the chief operating decision maker. | |||||||||
The following table summarizes revenue by geographic region (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
North America | $ | 7,943 | $ | 11,298 | |||||
Asia | 7,700 | 9,731 | |||||||
Europe | 12,306 | 15,458 | |||||||
Other | 977 | 247 | |||||||
$ | 28,926 | $ | 36,734 | ||||||
The Company determines geographic location of its revenue based upon the destination of shipments of its products. | |||||||||
During fiscal year 2013, Italy, the United States and Japan accounted for 39%, 24% and 13% of revenue, respectively. During fiscal year 2012, the United States, Italy, Hungary, and Japan accounted for 28%, 21%, 12%, and 11% of revenue, respectively. No other countries accounted for more than 10% of the Company’s consolidated revenue during the periods presented. | |||||||||
The following table summarizes revenue by product line (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
HSC | $ | 19,886 | $ | 21,307 | |||||
Industrial | 9,040 | 14,549 | |||||||
Government | - | 878 | |||||||
Total revenue | $ | 28,926 | $ | 36,734 | |||||
The following table summarizes long-lived assets by country (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
United States | $ | 2,004 | $ | 2,595 | |||||
Switzerland | 995 | 1,984 | |||||||
$ | 2,999 | $ | 4,579 | ||||||
Long-lived assets, comprising property and equipment, are reported based on the location of the assets. |
COMMITMENTS_AND_CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
COMMITMENTS AND CONTINGENCIES [Abstract] | ' | ||||||||
COMMITMENTS AND CONTINGENCIES | ' | ||||||||
NOTE 12—COMMITMENTS AND CONTINGENCIES | |||||||||
Commitments | |||||||||
Leases | |||||||||
The Company leases its domestic and foreign sales offices under non-cancelable operating leases. These leases contain various expiration dates and renewal options. The Company also leases certain software licenses under operating leases. Total rental expense for 2013 and 2012 was $560,000 and $575,000, respectively. | |||||||||
Aggregate non-cancelable future minimum lease payments under capital and operating leases are as follows (in thousands): | |||||||||
Capital Leases | Operating Leases | ||||||||
Years ending December 31, | Minmum lease payments | Minmum lease payments | |||||||
2014 | $ | 310 | $ | 643 | |||||
2015 | 4 | 351 | |||||||
2016 | 3 | 339 | |||||||
2017 and beyond | 3 | 57 | |||||||
Total minimum lease payments | 320 | $ | 1,390 | ||||||
Less: Amount representing interest | (26 | ) | |||||||
Total capital lease obligations | 294 | ||||||||
Less: current portion | (284 | ) | |||||||
Long-term portion of capital lease obligations | $ | 10 | |||||||
The gross and net book value of the fixed assets purchased under capital lease was as follows (in thousands): | |||||||||
As of the years December 31, | |||||||||
2013 | 2012 | ||||||||
Acquired cost | $ | 1,666 | $ | 1,653 | |||||
Accumulated amortization | (1,378 | ) | (1,047 | ) | |||||
Net book value | $ | 288 | $ | 606 | |||||
The amortization of fixed assets acquired under capital lease is included in depreciation expense. | |||||||||
Contingencies | |||||||||
Tax Contingencies | |||||||||
The Company’s income tax calculations are based on application of the respective U.S. Federal, state or foreign tax law. Its tax filings, however, are subject to audit by the respective tax authorities. Accordingly, the Company recognizes tax liabilities based upon its estimate of whether, and the extent to which, additional taxes will be due. | |||||||||
Legal Contingencies | |||||||||
From time to time, the Company may become involved in legal proceedings, claims and litigation arising in the ordinary course of business. When it believes a loss is probable and can be reasonably estimated, it accrues the estimated loss in its consolidated financial statements. Where the outcome of these matters is not determinable, it does not make a provision in its financial statements until the loss, if any, is probable and can be reasonable estimated or the outcome becomes known. | |||||||||
Product Warranties | |||||||||
The Company’s products typically carry a standard warranty period of approximately one year. The Company records a liability based on estimates of the costs that may be incurred under its warranty obligations and charges to the cost of product revenue the amount of such costs at the time revenues are recognized. The warranty obligation is affected by product failure rates, material usage and service delivery costs incurred in correcting a product failure. The estimates of anticipated rates of warranty claims and costs per claim are primarily based on historical information and future forecasts. | |||||||||
The table below summarizes the movement in the warranty accrual, which is included as a component of other current liabilities, for the years ended December 31, 2013 and 2012 (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Balance at January 1 | $ | 612 | $ | 296 | |||||
Warranties accrued | 510 | 1,328 | |||||||
Warranties settled or reversed | (792 | ) | (1,012 | ) | |||||
Balance at December 31 | $ | 330 | $ | 612 |
LEGAL_SETTLEMENT
LEGAL SETTLEMENT | 12 Months Ended |
Dec. 31, 2013 | |
LEGAL SETTLEMENTS [Abstract] | ' |
LEGAL SETTLEMENT | ' |
NOTE 13—LEGAL SETTLEMENT | |
On September 24, 2013, pursuant to the terms of a settlement agreement with M/A-COM Technology Solutions, Inc. (“MACOM”), Optomai, Inc., and three former employees of GigOptix, the Company received a payment of $7.25 million. The $7.25 million has been recorded as special litigation-related income, net of related legal fees in the operating section of the consolidated statements of operations. |
RECENT_ACCOUNTING_PRONOUNCEMEN
RECENT ACCOUNTING PRONOUNCEMENTS | 12 Months Ended |
Dec. 31, 2013 | |
RECENT ACCOUNTING PRONOUNCEMENTS [Abstract] | ' |
RECENT ACCOUNTING PRONOUNCEMENTS | ' |
NOTE 14—RECENT ACCOUNTING PRONOUNCEMENTS | |
In February 2013, the Financial Accounting Standards Board (“FASB”) issued an accounting standards update requiring centralized disclosure of amounts reclassified from accumulated other comprehensive income (“AOCI”) to net income. The amounts and the source reclassified out of each component of AOCI and the income statement line item affected by the reclassification should be presented either parenthetically on the face of the financial statements or in the notes. The entity does not need to show the income statement line item affected for certain components that are not required to be reclassified to net income in their entirety to net income, instead they would cross reference to the related footnote. This standard is effective for reporting periods beginning after December 15, 2012 and early adoption is permitted. The Company adopted this standard during 2013 and the adoption did not have a material impact on the Company’s consolidated financial statements. | |
In February 2013, the FASB issued an accounting standards update requiring disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation is fixed at the reporting date. The entity has to disclose the following information about each obligation: the nature of the arrangement, the total outstanding amount under the arrangement, the carrying amount of a liability and the carrying amount of a receivable recognized, the nature of any recourse provisions, how liability was measured initially, and where the entry was recorded in the financial statements. This standard is effective for fiscal years beginning after December 15, 2013 and early adoption is permitted. The Company adopted this standard during 2013 and the adoption did not have a material impact on the Company’s consolidated financial statements. | |
In March 2013, the FASB issued an accounting standards update requiring derecognition of certain subsidiaries or groups of assets within a foreign entity or of an investment in a foreign entity. For transactions occurring within a foreign entity, cumulative translation adjustment (“CTA”) would be released only upon complete or substantially complete liquidation of the foreign entity. Transactions within a foreign entity involve a component of a foreign entity, such as a subsidiary, a group of assets, or an equity investment. For transactions occurring in a foreign entity, CTA will be released based on the type of transaction. Transactions in a foreign entity involve a direct ownership interest of a foreign entity. This standard is effective for fiscal years beginning after December 15, 2013 and early adoption is permitted. The Company adopted this standard during 2013 and the adoption did not have a material impact on the Company’s consolidated financial statements. | |
In July 2013, the FASB issued an accounting standards update requiring disclosure of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The entity has to disclose an unrecognized tax benefit, or a portion of an unrecognized tax benefit that should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. The assessment of whether a deferred tax asset is available is based on the unrecognized tax benefit and deferred tax asset that exist at the reporting date and should be made presuming disallowance of the tax position at the reporting date. The standard is effective for fiscal years beginning after December 15, 2013. The Company adopted this standard during 2013 and the adoption did not have a material impact on the Company’s consolidated financial statements. |
SUBSEQUENT_EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Dec. 31, 2013 | |
SUBSEQUENT EVENTS [Abstract] | ' |
SUBSEQUENT EVENTS | ' |
NOTE 15—SUBSEQUENT EVENTS | |
On February 10, 2014, the Company entered into a Joint Venture and Quotaholders Agreement (the “Joint Venture Agreement”) with Fundação CPqD – Centro De Pesquisa e Desenvolvimento em Telecomunicações (“CPqD”), a foundation duly organized and existing under the laws of Brazil and based in Campinas, Brazil, and BrPhotonics Produtos Optoeletrônicos LTDA. (“BrP”), a business limited liability company organized in Brazil, pertaining to the inception of BrP as a newly established joint venture company headquartered in Campinas, Brazil which will be a provider of advanced high-speed devices for optical communications and integrated transceiver components that enable information streaming over communications networks. Under the terms of the Joint Venture Agreement, and pursuant to the terms of the Articles of Association of BrP, which have been simultaneously amended with the entry into the Joint Venture Agreement, the Company owns 49% of the quotas of the capital in BrP. CPqD owns the remaining 51% of the quotas of the capital of BrP. The Joint Venture Agreement will enter into force and take effect as to CPqD only after its terms and conditions are approved by CPqD’s Oversight Board, and the release of proceeds from a loan requested by CPqD before FINEP – Agência Brasileira da Inovação to support the establishment of BrP and the development of its corporate purpose and activities, and shall have a term of thirty years which automatically renews for a period of twenty years unless the Company or CPqD delivers written notice to the other at least fifteen months, and no later than twelve months, prior to the expiration of the thirty year term that it wishes to terminate the Joint Venture Agreement. | |
The Company and CPqD will transfer into BrP their knowledge-base and intellectual property of current existing technologies, and will jointly work through the partnership to enhance, develop, and commercialize advanced products based on these technologies. GigOptix will transfer to Brazil its Thin Film Polymer on Silicon (“TFPSTM”) technology, inventory related to the TFPSTM platform, as well as the complete production line equipment currently residing at its Bothell, Washington, facility. CPqD will transfer to BrP its Silicon Photonics (“SiPh”) technology, optical packaging expertise and design and testing capabilities. In addition, CPqD will provide space for the BrP corporate headquarters and the funding for the BrP operations. |
ORGANIZATION_AND_BASIS_OF_PRES1
ORGANIZATION AND BASIS OF PRESENTATION (Policies) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
ORGANIZATION AND BASIS OF PRESENTATION [Abstract] | ' | ||||||||
Organization | ' | ||||||||
Organization | |||||||||
GigOptix Inc. (“GigOptix” or the “Company”) is a leading fabless supplier of high speed semiconductor components that enable end-to-end information streaming over optical and wireless networks and address long haul and metro telecommunications applications as well as emerging high-growth opportunities for Cloud and datacenter connectivity, interactive applications for consumer electronics, high-speed optical and wireless networks, and the industrial, defense and avionics industries. The business is made up of two product lines: the High-Speed Communications (“HSC”) product line and the Industrial product line. | |||||||||
The HSC product line offers a broad portfolio of high performance optical and wireless components to telecommunications (“telecom”) and data communications (“datacom”) customers, i) mixed signal radio frequency integrated circuits (“RFIC”), including 10 to 400 gigabit per second (“Gbps”) laser and optical drivers and trans-impedance amplifiers (“TIA”) for telecom, datacom, and consumer electronic fiber-optic applications; ii) power amplifiers and transceivers for microwave and millimeter monolithic microwave integrated circuit (“MMIC”) wireless applications including 73 Ghz and 83 GHz power amplifiers and transceiver chips; and iii) integrated systems in a package (“SIP”) solutions for both fiber-optic and wireless applications. The HSC product line also partners with key customers on development projects that generate engineering project revenue for the Company while helping to position the Company for future product revenues with these key customers. | |||||||||
The Industrial product line offers a wide range of digital and mixed-signal application specific integrated circuit (“ASIC”) solutions for industrial, military, avionics, medical and communications markets. The Industrial product line partners with ASIC customers on development projects that generate engineering project revenue for the Company which generally leads to future product revenues with these ASIC customers. | |||||||||
The Company’s products focus on the specification, design, development and sale of analog semiconductor integrated circuits (“ICs”), multi-chip module (“MCM”) solutions, and digital and mixed signal ASICs, as well as wireless communications MMICs and modules. | |||||||||
GigOptix, Inc., the successor to GigOptix LLC, was formed as a Delaware corporation in March 2008 in order to facilitate a combination between GigOptix LLC and Lumera Corporation (“Lumera”). Before the combination, GigOptix LLC acquired the assets of iTerra Communications LLC in July 2007 (“iTerra”) and Helix Semiconductors AG (“Helix”) in January 2008. On November 9, 2009, GigOptix acquired ChipX, Incorporated (“ChipX”). On June 17, 2011, GigOptix acquired Endwave Corporation (“Endwave”). As a result of the acquisitions, Helix, Lumera, ChipX and Endwave all became wholly owned subsidiaries of GigOptix. | |||||||||
Reclassifications | ' | ||||||||
Reclassifications | |||||||||
Certain prior year amounts in the consolidated financial statements and the notes thereto have been reclassified where necessary to conform to the current year presentation. These reclassifications did not affect the prior period total assets, total liabilities, stockholders’ equity, net loss or net cash used in operating activities. | |||||||||
Basis of Presentation | ' | ||||||||
Basis of Presentation | |||||||||
The Company’s fiscal year ends on December 31. The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. | |||||||||
Use of Estimates | ' | ||||||||
Use of Estimates | |||||||||
The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“US GAAP”) requires management to make estimates, judgments and assumptions that affect the reported amount of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an on-going basis, the Company evaluates its estimates, including those related to allowances for doubtful accounts, reserves for stock rotation rights, warranty accrual, inventory write-downs, valuation of long-lived assets, including property and equipment and identified intangible assets and goodwill, valuation of deferred taxes and contingencies. In addition, the Company uses assumptions when employing the Black-Scholes option-pricing model to calculate the fair value of stock options granted; and assumptions when employing the Monte Carlo simulation to estimate the carrying value of its warrant liability. The Company bases its estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources. Actual results could differ from these estimates. | |||||||||
Certain Significant Risks and Uncertainties | ' | ||||||||
Certain Significant Risks and Uncertainties | |||||||||
The Company operates in a dynamic industry and, accordingly, its business can be affected by a variety of factors. For example, changes in any of the following areas could have a negative effect in terms of its future financial position, results of operations or cash flows: a downturn in the overall semiconductor industry or communications semiconductor market; regulatory changes; fundamental changes in the technology underlying telecom products or incorporated in customers’ products; market acceptance of its products under development; litigation or other claims against the Company; litigation or other claims made by the Company; the hiring, training and retention of key employees; integration of businesses acquired; successful and timely completion of product development efforts; and new product introductions by competitors. | |||||||||
Fair Value of Financial Instruments | ' | ||||||||
Fair Value of Financial Instruments | |||||||||
The Company’s financial instruments consist primarily of cash and cash equivalents, accounts receivable, accounts payable, and other accrued liabilities. The Company regularly reviews its investment portfolio to identify and evaluate investments that have indications of possible impairment. Factors considered in determining whether a loss is temporary include: the length of time and extent to which fair value has been lower than the cost basis; the financial condition, credit quality and near-term prospects of the investee; and whether it is more likely than not that the Company will be required to sell the security prior to any anticipated recovery in fair value. When there is no readily available market data, fair value estimates may be made by the Company, which may not necessarily represent the amounts that could be realized in a current or future sale of these assets. | |||||||||
Revenue Recognition | ' | ||||||||
Revenue Recognition | |||||||||
Revenue from sales of optical drivers and receivers, multi-chip modulators, and other products is recognized when persuasive evidence of a sales arrangement exists, transfer of title occurs, the sales price is fixed or determinable and collection of the resulting receivable is reasonably assured. Provisions are made for warranties at the time revenue is recorded. See Note 12—Commitments and Contingencies for further detail related to the warranty provision. | |||||||||
Customer purchase orders are generally used to determine the existence of an arrangement. Transfer of title and risk of ownership occur based on defined terms in customer purchase orders, and generally pass to the customer upon shipment, at which point goods are delivered to a carrier. There are no formal customer acceptance terms or further obligations, outside of standard product warranty. The Company assesses whether the sales price is fixed or determinable based on the payment terms associated with the transaction. Collectibility is assessed based primarily on the credit worthiness of the customer as determined through ongoing credit evaluations of the customer’s financial condition, as well as consideration of the customer’s payment history. | |||||||||
The Company records revenue from non-recurring engineering projects associated with product development that the Company enters into with certain customers. In general, these projects are associated with complex technology development, and as such the Company does not have certainty about its ability to achieve the program milestones. Achievement of the milestone is dependent on the Company’s performance and is typically accepted by the customer. The payment associated with achieving the milestone is generally commensurate with the Company’s effort or the value of the deliverable and is nonrefundable. Therefore, the Company records the expenses related to these projects in the periods incurred and recognizes revenue only when the Company has earned the revenue and achieved the development milestones. Revenue from these projects are typically recorded at 100% gross margin because the costs associated with these projects are expensed as incurred and generally included in research and development expense. These efforts generally benefit the Company’s overall product development programs beyond the specific project requested by our customer. | |||||||||
The Company sells some products to distributors at the price listed in its price book for that distributor. The Company's distributor agreements provide for semi-annual stock rotation privileges of 5% to 10% of net sales for the previous six-month period. At the time of sale, the Company records a sales reserve for stock rotations approved by management. The Company offsets the sales reserve against revenues, producing the net revenue amount reported in the consolidated statements of operations. Each month the Company adjusts the sales reserve for the estimated stock rotation privilege anticipated to be utilized by the distributors. When the distributors pay the Company's invoices, they may claim stock rotations when appropriate. Once claimed, the Company processes the requests against the prior authorizations and reduces the reserve previously established for that customer. As of December 31, 2013 and 2012, the reserve for stock rotations was $151,000 and $65,000, respectively, and is recorded in other current liabilities on the consolidated balance sheets. | |||||||||
The Company records transaction-based taxes including, but not limited to, sales, use, value added, and excise taxes, on a net basis in its consolidated statements of operations. | |||||||||
Accounts Receivable and Allowance for Doubtful Accounts | ' | ||||||||
Accounts Receivable and Allowance for Doubtful Accounts | |||||||||
Accounts receivable are recorded at the invoiced amount and are not interest bearing. The Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company makes ongoing assumptions relating to the collectibility of its accounts receivable in its calculation of the allowance for doubtful accounts. In determining the amount of the allowance, the Company makes judgments about the creditworthiness of customers based on ongoing credit evaluations and assesses current economic trends affecting its customers that might impact the level of credit losses in the future and result in different rates of bad debts than previously seen. The Company also considers its historical level of credit losses. As of December 31, 2013, the Company’s accounts receivable balance was $5.0 million, which was net of an allowance for doubtful accounts of $220,000. As of December 31, 2012, the Company’s accounts receivable balance was $5.1 million, which was net of an allowance for doubtful accounts of $337,000. | |||||||||
Cash and Cash Equivalents | ' | ||||||||
Cash and Cash Equivalents | |||||||||
The Company considers all highly liquid investments with an original maturity of 90 days or less at the date of purchase to be cash equivalents. Cash and cash equivalents are maintained at various financial institutions. | |||||||||
Concentration of Credit Risk | ' | ||||||||
Concentration of Credit Risk | |||||||||
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, and accounts receivable. The Company maintains cash and cash equivalents with various financial institutions that management believes to be of high credit quality. At any time, amounts held at any single financial institution may exceed federally insured limits. The Company believes that the concentration of credit risk in its accounts receivable is substantially mitigated by its credit evaluation process, relatively short collection terms and the high level of credit worthiness of its customers. The Company performs ongoing credit evaluations of its customers’ financial condition and limits the amount of credit extended when deemed necessary but generally requires no collateral. | |||||||||
As of December 31, 2013, two customers accounted for 29% and 17% of total accounts receivable. As of December 31, 2012, one customer accounted for 31% of total accounts receivable. | |||||||||
For the year ended December 31, 2013, one customer accounted for 33% of total revenue. For the year ended December 31, 2012, two customers accounted for 22% and 12% of total revenue. | |||||||||
Concentration of Supply Risk | ' | ||||||||
Concentration of Supply Risk | |||||||||
The Company relies on third parties to manufacture its products, and depends on them for the supply and quality of its products. Quality or performance failures of the Company’s products or changes in its manufacturers’ financial or business condition could disrupt the Company’s ability to supply quality products to its customers and thereby have a material and adverse effect on its business and operating results. Some of the components and technologies used in the Company’s products are purchased and licensed from a single source or a limited number of sources. The loss of any of these suppliers may cause the Company to incur additional transition costs, result in delays in the manufacturing and delivery of its products, or cause it to carry excess or obsolete inventory or redesign its products. The Company relies on a third party for the fulfillment of its customer orders, and the failure of this third party to perform could have an adverse effect upon the Company’s reputation and its ability to distribute its products, which could adversely affect the Company’s business. | |||||||||
Inventories | ' | ||||||||
Inventories | |||||||||
Inventories are stated at the lower of standard cost, which approximates actual cost on a first-in, first-out basis, or market (net realizable value). Cost includes labor, material and overhead costs. Determining fair market value of inventories involves numerous judgments, including projecting average selling prices and sales volumes for future periods and costs to complete products in work in process inventories. As a result of this analysis, when fair market values are below costs, the Company records a charge to cost of revenue in advance of when the inventory is scrapped or sold. | |||||||||
The Company evaluates its ending inventories for excess quantities and obsolescence on a quarterly basis. This evaluation includes analysis of historical and forecasted sales levels by product against inventories on-hand. Inventories on-hand in excess of estimated future demand are reviewed by management to determine if a write-down is required. In addition, the Company writes-off inventories that are considered obsolete. Obsolescence is determined from several factors, including competitiveness of product offerings, market conditions and product life cycles when determining obsolescence. Excess and obsolete inventories are charged to cost of revenue and a new, lower-cost basis for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. | |||||||||
The Company’s inventories include high-technology parts that may be subject to rapid technological obsolescence and which are sold in a highly competitive industry. If actual product demand or selling prices are less favorable than forecasted amounts, the Company may be required to take additional inventory write-downs. | |||||||||
Property and Equipment | ' | ||||||||
Property and Equipment | |||||||||
Property and equipment, including leasehold improvements, are recorded at cost and depreciated using the straight-line method over their estimated useful lives, ranging from one to seven years. Leasehold improvements and assets acquired under capital leases are depreciated over the lesser of their estimated useful lives or the remaining lease term of the respective assets. Repairs and maintenance costs are charged to expenses as incurred. | |||||||||
Long-lived Assets | ' | ||||||||
Long-lived Assets | |||||||||
Long-lived assets include equipment, furniture and fixtures, licenses, leasehold improvements, semiconductor masks used in production and intangible assets. When events or changes in circumstances indicate that the carrying amount of long-lived assets may not be recoverable, the Company tests for recoverability by comparing the estimate of undiscounted cash flows to be generated by the assets against the assets’ carrying amount. If the carrying value exceeds the estimated future cash flows, the assets are considered to be impaired. The amount of impairment equals the difference between the carrying amount of the assets and their fair value. Factors the Company considers important that could trigger an impairment review include continued operating losses, significant negative industry trends, significant underutilization of the assets and significant changes in how it plans to use the assets. | |||||||||
Intangible assets are amortized on a straight-line basis over their estimated economic lives of six to seven years for existing technology, acquired in business combinations; five to sixteen years for patents acquired in business combinations, based on the term of the patent or the estimated useful life, whichever is shorter; one year for order backlog, acquired in business combinations; ten years for trade name, acquired in business combinations; and three to eight years for customer relationships, acquired in business combinations. | |||||||||
Goodwill | ' | ||||||||
Goodwill | |||||||||
Goodwill is recorded when the purchase price of an acquisition exceeds the fair value of the net purchased tangible and intangible assets acquired and is carried at cost. Goodwill is not amortized, but is reviewed annually for impairment. The Company performs its annual goodwill impairment analysis in the fourth quarter of each year or more frequently if it believes indicators of impairment exist. Factors that it considers important which could trigger an impairment review include the following: | |||||||||
· | significant underperformance relative to historical or projected future operating results; | ||||||||
· | significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition; | ||||||||
· | significant negative industry or economic trends; and | ||||||||
· | significant decline in the Company’s market capitalization. | ||||||||
When evaluating goodwill for impairment, the Company may initially perform a qualitative assessment which includes a review and analysis of certain quantitative factors to estimate if a reporting units’ fair value significantly exceeds its carrying value. When the estimate of a reporting unit’s fair value appears more likely than not to be less than its carrying value based on this qualitative assessment, the Company continues to the first step of a two step impairment test. The first step requires a comparison of the fair value of the reporting unit to its net book value, including goodwill. The fair value of the reporting units is determined based on a weighting of income and market approaches. Under the income approach, the Company calculates the fair value of a reporting unit based on the present value of estimated future cash flows. Under the market approach, the Company estimates the fair value based on market multiples of revenue or earnings for comparable companies. Determining the fair value of a reporting unit is judgmental in nature and involves the use of significant estimates and assumptions. These estimates and assumptions include revenue growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, and future economic and market conditions and determination of appropriate market comparables. The Company bases these fair value estimates on reasonable assumptions but that are unpredictable and inherently uncertain. Actual future results may differ from those estimates. A potential impairment exists if the fair value of the reporting unit is lower than its net book value. The second step of the process is only performed if a potential impairment exists, and it involves determining the difference between the fair values of the reporting unit’s net assets, other than goodwill, and the fair value of the reporting unit, and, if the difference is less than the net book value of goodwill, an impairment charge is recorded. In the event that the Company determines that the value of goodwill has become impaired, it will record a charge for the amount of impairment during the fiscal quarter in which the determination is made. The Company operates in one reporting unit. The Company conducted its 2013 annual goodwill impairment analysis in the fourth quarter of 2013 and no goodwill impairment was indicated. | |||||||||
Restricted Cash | ' | ||||||||
Restricted Cash | |||||||||
Restricted cash as of December 31, 2013 and 2012 consists of $284,000 and $282,000, respectively, which includes $151,000 in satisfaction of the letter of credit provisions of the Company’s Bothell, Washington facility lease which has a lease term ending the first quarter of 2014, $58,000 and $56,000, respectively, held in an escrow account related to its facility lease in Zurich, Switzerland, for which it is management’s expectation to continue to renew this lease beyond the current year and $75,000 with Silicon Valley Bank to secure its credit card. Restricted cash is held in interest-bearing cash accounts and is classified as long term. | |||||||||
Pension Liabilities | ' | ||||||||
Pension Liabilities | |||||||||
The Company maintains a defined benefit pension plan covering minimum requirements according to Swiss law for its Zurich, Switzerland employees. The Company recognizes the funded status of its defined benefit pension plan on its consolidated balance sheets and changes in the funded status are reflected in accumulated other comprehensive income, net of tax, a component of stockholders’ equity. | |||||||||
Net periodic pension costs are calculated based upon a number of actuarial assumptions, including a discount rate for plan obligations, assumed rate of return on pension plan assets and assumed rate of compensation increases for plan employees. All of these assumptions are based upon management’s judgment, considering all known trends and uncertainties. Actual results that differ from these assumptions would impact the future expense recognition and cash funding requirements of its pension plans. | |||||||||
Foreign Currency | ' | ||||||||
Foreign Currency | |||||||||
The financial position and results of operations of the Company’s foreign subsidiaries are measured using the local currency as their functional currency. Accordingly, all assets and liabilities for these subsidiaries are translated into U.S. dollars at the current exchange rates as of the respective balance sheet date. Revenue and expense items are translated at the average exchange rates prevailing during the period. Cumulative gains and losses from the translation of these subsidiaries’ financial statements are reported as a separate component of accumulated other comprehensive income, net of tax, a component of stockholders’ equity. The Company records foreign currency transaction gains and losses, realized and unrealized, in other income (expense), net in the consolidated statements of operations. The Company recorded approximately $11,000 of net transaction loss in 2013 and $41,000 of net transaction gain in 2012. | |||||||||
Product Warranty | ' | ||||||||
Product Warranty | |||||||||
The Company’s products typically carry a standard warranty period of approximately one year which provides for the repair, rework or replacement of products (at its option) that fail to perform within stated specification. The Company provides for the estimated cost to repair or replace the product at the time of sale. The warranty accrual is estimated based on historical claims and assumes that it will replace products subject to claims. | |||||||||
Shipping Costs | ' | ||||||||
Shipping Costs | |||||||||
The Company charges shipping costs to cost of revenue as incurred. | |||||||||
Research and Development Expense | ' | ||||||||
Research and Development Expense | |||||||||
Research and development expenses are expensed as incurred. Research and development expense consists primarily of salaries and related expenses for research and development personnel, consulting and engineering design, non-capitalized tools and equipment, engineering related semiconductor masks, depreciation for equipment, engineering expenses paid to outside technology development suppliers, allocated facilities costs and expenses related to stock-based compensation. | |||||||||
Advertising Expense | ' | ||||||||
Advertising Expense | |||||||||
Advertising costs are expensed as incurred. Advertising expenses, which are recorded in selling, general and administrative expenses, were approximately $46,000 and $66,000 for the years ended December 31, 2013 and 2012, respectively. | |||||||||
Stock-Based Compensation | ' | ||||||||
Stock-Based Compensation | |||||||||
Stock-based compensation is measured at the date of grant, based on the fair value of the award. For options, the Company amortizes the compensation costs on a straight-line basis over the requisite service period of the option, which is generally the option vesting term of four years. For restricted stock units (“RSU”), the Company amortizes the compensation costs on a straight-line basis over the requisite service period of the RSU grant, which is generally the vesting term of one to four years. The benefits of tax deductions in excess of recognized compensation expense are reported as a financing cash flow. All of the stock compensation is accounted for as an equity instrument. | |||||||||
For RSUs, stock-based compensation is based on the fair value of the Company’s common stock at the grant date. | |||||||||
Stock-based compensation expense is measured at grant date, based on the estimated fair value of the awards ultimately expected to vest and is recognized as an expense, on a straight-line basis, over the requisite service period. The Company uses the Black-Scholes option-pricing model to measure the fair value of its stock-based awards utilizing various assumptions with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield. | |||||||||
Management estimates expected forfeitures and it records the stock compensation expense only for those equity awards expected to vest. When estimating forfeitures, the Company considers voluntary termination behavior as well as an analysis of actual option forfeitures. Forfeitures are required to be estimated at the time of grant and revised if necessary in subsequent periods if actual forfeitures or vesting differ from those estimates. Such revisions could have a material effect on its operating results. The assumptions the Company uses in the valuation model are based on subjective future expectations combined with management judgment. If any of the assumptions used in the Black-Scholes option-pricing model changes significantly, stock-based compensation for future awards may differ materially compared to the awards granted previously. | |||||||||
The fair value of RSUs granted is the product of the number of shares granted and the grant date fair value of the Company’s common stock. RSUs are converted into shares of the Company’s common stock upon vesting on a one-for-one basis. Typically, vesting of RSUs is subject to the employee's continuing service to the Company. RSUs generally vest over a period of one to four years and are expensed ratably on a straight-line basis over their respective vesting period net of estimated forfeitures. | |||||||||
Warrants | ' | ||||||||
Warrants | |||||||||
Warrants issued as equity awards are recorded based on the estimated fair value of the awards at the grant date. The Company uses the Black-Scholes option-pricing model to measure the fair value of its equity warrant awards utilizing various assumptions with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield. | |||||||||
Warrants with certain features, including down-round protection, are recorded as liability awards. These warrants are valued using a Black-Scholes option-pricing model which requires various assumptions with respect to expected holding period, risk-free interest rates, stock price volatility and dividend yield. The warrants are recorded as a liability each reporting period, and the change in the fair value of the liability is recorded as other income (expense), net until the warrant is exercised or cancelled. | |||||||||
Net Loss per Share | ' | ||||||||
Net Loss per Share | |||||||||
Basic net loss per share is computed using the weighted average number of common shares outstanding. The number of shares used in the computation of diluted net loss per share is the same as those used for the computation of basic net loss per share as the inclusion of dilutive securities would be anti-dilutive because the Company is in a loss position for the periods presented. Potentially dilutive securities are composed of the incremental common shares issuable upon the exercise of stock options and the vesting of RSUs awards. For purposes of the diluted net loss per share calculation, RSUs, stock options to purchase common stock and warrants to purchase common stock are considered to be dilutive securities. | |||||||||
Income Taxes | ' | ||||||||
Income Taxes | |||||||||
The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from differences between the financial and tax basis of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. | |||||||||
The calculation of tax liabilities involves dealing with uncertainties in the application of complex global tax regulations. The Company recognizes potential liabilities for anticipated tax audit issues in the U.S. and other tax jurisdictions based on its estimate of whether, and the extent to which, additional taxes will be due. If payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when it determines the liabilities are no longer necessary. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result. | |||||||||
Comprehensive Income (Loss) | ' | ||||||||
Comprehensive Income (Loss) | |||||||||
Comprehensive income (loss) is comprised of two components: net loss and other comprehensive income (loss). Other comprehensive income (loss) refers to revenues, expenses, gains and losses that under U.S. GAAP are recorded as an element of stockholders’ equity, but are excluded from net loss. Accumulated other comprehensive income in the accompanying consolidated balance sheets includes foreign currency translation adjustments arising from the consolidation of the Company’s foreign subsidiaries and its pension liabilities. Comprehensive income (loss) is presented net of income tax and the tax impact is immaterial. | |||||||||
The components of accumulated other comprehensive income (loss) were as follows (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Accumulated comprehensive income: | |||||||||
Foreign currency translation adjustment, net of tax | $ | 353 | $ | 262 | |||||
Change in pension liability in connection with actuarial gain, net of tax | 137 | 36 | |||||||
Total | $ | 490 | $ | 298 |
ORGANIZATION_AND_BASIS_OF_PRES2
ORGANIZATION AND BASIS OF PRESENTATION (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
ORGANIZATION AND BASIS OF PRESENTATION [Abstract] | ' | ||||||||
Schedule of accumulated other comprehensive income (loss) | ' | ||||||||
The components of accumulated other comprehensive income (loss) were as follows (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Accumulated comprehensive income: | |||||||||
Foreign currency translation adjustment, net of tax | $ | 353 | $ | 262 | |||||
Change in pension liability in connection with actuarial gain, net of tax | 137 | 36 | |||||||
Total | $ | 490 | $ | 298 |
BALANCE_SHEET_COMPONENTS_Table
BALANCE SHEET COMPONENTS (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
BALANCE SHEET COMPONENTS [Abstract] | ' | |||||||||||
Accounts receivable, net | ' | |||||||||||
Accounts receivable, net, consisted of the following, as of (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Accounts receivable | $ | 5,241 | $ | 5,393 | ||||||||
Allowance for doubtful accounts | (220 | ) | (337 | ) | ||||||||
$ | 5,021 | $ | 5,056 | |||||||||
Property and equipment, net | ' | |||||||||||
Property and equipment, net consisted of the following, as of (in thousands, except depreciable life): | ||||||||||||
Life | December 31, | |||||||||||
(In years) | 2013 | 2012 | ||||||||||
Network and laboratory equipment | 3 – 5 | $ | 11,250 | $ | 10,654 | |||||||
Computer software and equipment | 2 – 3 | 3,928 | 3,747 | |||||||||
Furniture and fixtures | 3 – 7 | 176 | 176 | |||||||||
Office equipment | 3 – 5 | 137 | 106 | |||||||||
Leasehold improvements | 1 – 5 | 378 | 378 | |||||||||
Construction-in-progress | — | - | 236 | |||||||||
15,869 | 15,297 | |||||||||||
Accumulated depreciation and amortization | (12,870 | ) | (10,718 | ) | ||||||||
Property and equipment, net | $ | 2,999 | $ | 4,579 | ||||||||
Inventories | ' | |||||||||||
Inventories consisted of the following, as of (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Raw materials | $ | 2,103 | $ | 2,290 | ||||||||
Work in process | 780 | 687 | ||||||||||
Finished goods | 1,734 | 1,134 | ||||||||||
$ | 4,617 | $ | 4,111 | |||||||||
Other current liabilities | ' | |||||||||||
Other current liabilities consisted of the following, as of (in thousands): | ||||||||||||
December 31, | ||||||||||||
2013 | 2012 | |||||||||||
Amounts billed to the U.S. government in excess of approved rates | $ | 191 | $ | 191 | ||||||||
Warranty liability | 330 | 612 | ||||||||||
Customer deposits | 313 | 432 | ||||||||||
Capital lease obligation, current portion | 284 | 324 | ||||||||||
Restructuring liabilities | 30 | 168 | ||||||||||
Sales return reserve | 151 | 65 | ||||||||||
Other | 1,447 | 1,288 | ||||||||||
$ | 2,746 | $ | 3,080 |
FAIR_VALUE_MEASUREMENTS_Tables
FAIR VALUE MEASUREMENTS (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS [Abstract] | ' | ||||||||||||||||||||||||||||||||||||||||
Financial assets and liabilities measured at fair value, recurring basis | ' | ||||||||||||||||||||||||||||||||||||||||
The following table summarizes the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2013 and 2012 (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Fair Value Measurements Using | |||||||||||||||||||||||||||||||||||||||||
Carrying Value | Quoted | Significant | Significant | ||||||||||||||||||||||||||||||||||||||
Prices in | Other | Unobservable | |||||||||||||||||||||||||||||||||||||||
Active | Observable | Inputs | |||||||||||||||||||||||||||||||||||||||
Markets for | Inputs | (Level 3) | |||||||||||||||||||||||||||||||||||||||
Identical | (Level 2) | ||||||||||||||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||||||||||||||
(Level 1) | |||||||||||||||||||||||||||||||||||||||||
December 31, 2013: | |||||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||||||||||
Money market funds | $ | 1,356 | $ | 1,356 | $ | - | $ | - | |||||||||||||||||||||||||||||||||
$ | 1,356 | $ | 1,356 | $ | - | $ | - | ||||||||||||||||||||||||||||||||||
Current liabilities: | |||||||||||||||||||||||||||||||||||||||||
Liability warrants | $ | 15 | $ | - | $ | - | $ | 15 | |||||||||||||||||||||||||||||||||
December 31, 2012: | |||||||||||||||||||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||||||||||
Money market funds | $ | 2,856 | $ | 2,856 | $ | - | $ | - | |||||||||||||||||||||||||||||||||
$ | 2,856 | $ | 2,856 | $ | - | $ | - | ||||||||||||||||||||||||||||||||||
Current liabilities: | |||||||||||||||||||||||||||||||||||||||||
Liability warrants | $ | 24 | $ | - | $ | - | $ | 24 | |||||||||||||||||||||||||||||||||
Estimate of fair value for warrants assumptions | ' | ||||||||||||||||||||||||||||||||||||||||
The fair value of the warrants was estimated using the following assumptions: | |||||||||||||||||||||||||||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
Stock price | $ | 1.53 | $ | 1.92 | |||||||||||||||||||||||||||||||||||||
Strike price | $ | 2.51 | $ | 3.32 | |||||||||||||||||||||||||||||||||||||
Expected life | 3.55 years | 4.55 years | |||||||||||||||||||||||||||||||||||||||
Risk-free interest rate | 1.3 | % | 0.62 | % | |||||||||||||||||||||||||||||||||||||
Volatility | 65 | % | 85 | % | |||||||||||||||||||||||||||||||||||||
Fair value per share | $ | 0.52 | $ | 1.03 | |||||||||||||||||||||||||||||||||||||
Warrants subject to liability accounting | ' | ||||||||||||||||||||||||||||||||||||||||
The following table summarizes the warrants subject to liability accounting as of December 31, 2013 and 2012 (in thousands, except share and per share amounts) (see also Note 6 – Stockholders’ Equity): | |||||||||||||||||||||||||||||||||||||||||
Year Ended December 31, 2013 | Year Ended December 31, 2012 | ||||||||||||||||||||||||||||||||||||||||
Holder | Original | Adjusted | Grant Date | Expiration Date | Price | Fair Value | Fair Value | Exercise of Warrants | Change in Fair Value | Exercise of Warrants | Change in Fair Value | Related | |||||||||||||||||||||||||||||
Warrants | Warrants | per | 31-Dec-13 | December 31, 2012 | Agreement | ||||||||||||||||||||||||||||||||||||
Share | |||||||||||||||||||||||||||||||||||||||||
Bridge Bank | 20,000 | 29,115 | 4/7/10 | 7/7/17 | $ | 2.51 | $ | 15 | $ | 24 | - | $ | (9 | ) | - | $ | 3 | Credit Agreement | |||||||||||||||||||||||
Change in the fair value of level 3 liabilities | ' | ||||||||||||||||||||||||||||||||||||||||
The change in the fair value of Level 3 liabilities is as follows (in thousands): | |||||||||||||||||||||||||||||||||||||||||
Fair value at December 31, 2011 | $ | 21 | |||||||||||||||||||||||||||||||||||||||
Exercise of warrants | - | ||||||||||||||||||||||||||||||||||||||||
Change in fair value | 3 | ||||||||||||||||||||||||||||||||||||||||
Fair value at December 31, 2012 | 24 | ||||||||||||||||||||||||||||||||||||||||
Exercise of warrants | - | ||||||||||||||||||||||||||||||||||||||||
Change in fair value | (9 | ) | |||||||||||||||||||||||||||||||||||||||
Fair value at December 31, 2013 | $ | 15 |
INTANGIBLE_ASSETS_AND_GOODWILL1
INTANGIBLE ASSETS AND GOODWILL (Tables) | 12 Months Ended | ||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||
INTANGIBLE ASSETS AND GOODWILL [Abstract] | ' | ||||||||||||||||||||||||
Intangible assets | ' | ||||||||||||||||||||||||
Intangible assets consist of the following (in thousands): | |||||||||||||||||||||||||
As of December 31, 2013 | As of December 31, 2012 | ||||||||||||||||||||||||
Gross | Accumulated | Net | Gross | Accumulated | Net | ||||||||||||||||||||
Amortization | Amortization | ||||||||||||||||||||||||
Customer relationships | $ | 3,277 | $ | (1,697 | ) | $ | 1,580 | $ | 3,277 | $ | (1,274 | ) | $ | 2,003 | |||||||||||
Existing technology | 3,783 | (2,473 | ) | 1,310 | 3,783 | (2,065 | ) | 1,718 | |||||||||||||||||
Order backlog | 732 | (732 | ) | - | 732 | (732 | ) | - | |||||||||||||||||
Patents | 457 | (397 | ) | 60 | 457 | (321 | ) | 136 | |||||||||||||||||
Trade name | 659 | (322 | ) | 337 | 659 | (246 | ) | 413 | |||||||||||||||||
Total | $ | 8,908 | $ | (5,621 | ) | $ | 3,287 | $ | 8,908 | $ | (4,638 | ) | $ | 4,270 | |||||||||||
Amortization of intangible assets | ' | ||||||||||||||||||||||||
During the year ended December 31, 2013 and 2012, amortization of intangible assets was as follows (in thousands): | |||||||||||||||||||||||||
31-Dec-13 | 31-Dec-12 | ||||||||||||||||||||||||
Cost of revenue | $ | 484 | $ | 489 | |||||||||||||||||||||
Selling, general and administrative expense | 499 | 522 | |||||||||||||||||||||||
$ | 983 | $ | 1,011 | ||||||||||||||||||||||
Estimated future amortization expense | ' | ||||||||||||||||||||||||
Estimated future amortization expense related to intangible assets as of December 31, 2013 is as follows (in thousands): | |||||||||||||||||||||||||
Years ending December 31, | |||||||||||||||||||||||||
2014 | $ | 893 | |||||||||||||||||||||||
2015 | 893 | ||||||||||||||||||||||||
2016 | 869 | ||||||||||||||||||||||||
2017 | 487 | ||||||||||||||||||||||||
2018 | 145 | ||||||||||||||||||||||||
Total | $ | 3,287 |
STOCKHOLDERS_EQUITY_Tables
STOCKHOLDERS' EQUITY (Tables) | 12 Months Ended | ||||||||||||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||||||||||||
STOCKHOLDERS' EQUITY [Abstract] | ' | ||||||||||||||||||||||||||||||||
Schedule of Stockholders' equity note, warrants | ' | ||||||||||||||||||||||||||||||||
As of December 31, 2013, the Company had a total of 1,468,239 warrants to purchase common stock outstanding under all warrant arrangements. During the year ended December 31, 2012, 137,500 warrants were exercised that resulted in the issuance of 14,158 shares of common stock. There were no warrants exercised during the year ended December 31, 2013. During the year ended December 31, 2013, 348,800 warrants expired. There were no warrants that expired during the year ended December 31, 2012. Many of the warrants have anti-dilution provisions which adjust the number of warrants available to the holder such as, but not limited to, stock dividends, stock splits, and certain reclassifications, exchanges, combinations or substitutions. These provisions are specific to each warrant agreement. | |||||||||||||||||||||||||||||||||
Warrants Outstanding as of | Warrants Expired | Warrants Exercised | |||||||||||||||||||||||||||||||
December 31, | During the Year Ended | During the Year Ended | |||||||||||||||||||||||||||||||
December 31, | December 31, | ||||||||||||||||||||||||||||||||
Holder | Exercise Price | Expiration | 2013 | 2012 | 2013 | 2012 | |||||||||||||||||||||||||||
per Share | Date | ||||||||||||||||||||||||||||||||
Alliance Advisors LLC | $ | 1.75 | 7/20/14 | 25,000 | 25,000 | - | - | ||||||||||||||||||||||||||
Bridge Bank | $ | 2.51 | 7/7/17 | 29,115 | 22,671 | - | - | ||||||||||||||||||||||||||
Warrants issued to PIPE investros | $ | 2.5 | 12/28/13 | - | 242,500 | 242,500 | 137,500 | ||||||||||||||||||||||||||
Sandgrain Securities Inc. | $ | 2.5 | 12/28/13 | - | 4,000 | 4,000 | - | ||||||||||||||||||||||||||
Warrants issued to investors in connection with the Lumera Merger | $ | 24 | 2/21/13 | - | 22,500 | 22,500 | - | ||||||||||||||||||||||||||
Warrants issued to investors in connection with the Lumera Merger | $ | 6.08 | 1/16/14 | 284,999 | 284,999 | - | - | ||||||||||||||||||||||||||
Silicon Valley Bank | $ | 0.73 | 10/5/17 | 4,125 | 4,125 | - | - | ||||||||||||||||||||||||||
Silicon Valley Bank | $ | 4 | 4/23/17 | 125,000 | 125,000 | - | - | ||||||||||||||||||||||||||
Warrants issued to GigOptix LLC executives in connection with the Lumera Merger | $ | 6.08 | 7/16/13 | - | 79,800 | 79,800 | - | ||||||||||||||||||||||||||
DBSI Liquidating Trust | $ | 2.6 | 4/8/14 | 500,000 | 500,000 | - | - | ||||||||||||||||||||||||||
DBSI Liquidating Trust | $ | 3 | 4/8/15 | 500,000 | 500,000 | - | - | ||||||||||||||||||||||||||
1,468,239 | 1,810,595 | 348,800 | 137,500 | ||||||||||||||||||||||||||||||
Schedule of stock-based compensation expense | ' | ||||||||||||||||||||||||||||||||
The following table summarizes the Company’s stock-based compensation expense for fiscal years 2013 and 2012 (in thousands): | |||||||||||||||||||||||||||||||||
Years ended December 31, | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Cost of revenue | $ | 263 | $ | 230 | |||||||||||||||||||||||||||||
Research and development expense | 1,034 | 1,579 | |||||||||||||||||||||||||||||||
Selling, general and administrative expense | 2,257 | 3,146 | |||||||||||||||||||||||||||||||
Restructuring expense | 662 | 132 | |||||||||||||||||||||||||||||||
$ | 4,216 | $ | 5,087 | ||||||||||||||||||||||||||||||
Summary of option activity | ' | ||||||||||||||||||||||||||||||||
The following is a summary of option activity for the Company’s equity incentive plans, including both the 2008 Plan and other prior plans for which there are outstanding options but no new grants since the 2008 Plan was adopted: | |||||||||||||||||||||||||||||||||
Years Ended December 31, | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Options | Weighted-average | Weighted-average | Aggregate | Options | Weighted- | Weighted-average | Aggregate | ||||||||||||||||||||||||||
Exercise Price | Remaining | Intrinsic | average | Remaining | Intrinsic | ||||||||||||||||||||||||||||
Contractual Term, | Value, in Thousands | Exercise Price | Contractual Term, | Value, in | |||||||||||||||||||||||||||||
in Years | in Years | Thousands | |||||||||||||||||||||||||||||||
Outstanding, beginning of year | 10,100,429 | $ | 2.42 | 8,495,725 | $ | 2.58 | |||||||||||||||||||||||||||
Granted | 689,010 | $ | 0.92 | 2,771,533 | $ | 2.64 | |||||||||||||||||||||||||||
Exercised | (12,221 | ) | $ | 1.09 | $ | 3 | (230,466 | ) | $ | 1.73 | $ | 178 | |||||||||||||||||||||
Forfeited/Expired | (470,547 | ) | $ | 2.12 | (936,363 | ) | $ | 4.65 | |||||||||||||||||||||||||
Balance, end of year | 10,306,671 | $ | 2.34 | 6.96 | $ | 1,405 | 10,100,429 | $ | 2.42 | 7.81 | $ | 1,874 | |||||||||||||||||||||
Vested and exercisable and expected to vest, end of year | 10,101,382 | $ | 2.34 | 6.93 | $ | 1,379 | 9,512,994 | $ | 2.43 | 7.77 | $ | 1,868 | |||||||||||||||||||||
Vested and exercisable, end of year | 7,297,096 | $ | 2.39 | 6.47 | $ | 1,017 | 5,004,706 | $ | 2.32 | 6.92 | $ | 1,809 | |||||||||||||||||||||
Summarizes information about options granted and outstanding under our equity incentive plans | ' | ||||||||||||||||||||||||||||||||
The following table summarizes information about options outstanding and exercisable under the Company’s equity incentive plans as of December 31, 2013: | |||||||||||||||||||||||||||||||||
Options Outstanding | Options Exercisable | ||||||||||||||||||||||||||||||||
Number of Shares | Weighted- | Weighted- | Exercisable | Weighted- | |||||||||||||||||||||||||||||
Outstanding | average | average | average | ||||||||||||||||||||||||||||||
Remaining | Exercise | Exercise Price | |||||||||||||||||||||||||||||||
Contractual Life, | Price | ||||||||||||||||||||||||||||||||
in Years | |||||||||||||||||||||||||||||||||
$ | 0.73 – $1.83 | 2,836,418 | 6.03 | $ | 1.04 | 2,075,768 | $ | 1.05 | |||||||||||||||||||||||||
$ | 1.86 – $2.40 | 2,044,982 | 6.6 | $ | 2.15 | 1,780,182 | $ | 2.14 | |||||||||||||||||||||||||
$ | 2.50 – $2.70 | 5,055,034 | 7.73 | $ | 2.63 | 3,083,900 | $ | 2.62 | |||||||||||||||||||||||||
$ | 3.03 – $18.16 | 308,759 | 6.02 | $ | 4.11 | 295,768 | $ | 4.16 | |||||||||||||||||||||||||
$ | 18.18 – $57.44 | 61,478 | 2.67 | $ | 35.61 | 61,478 | $ | 35.61 | |||||||||||||||||||||||||
$ | 0.73 – $57.44 | 10,306,671 | 6.96 | $ | 2.34 | 7,297,096 | $ | 2.39 | |||||||||||||||||||||||||
Summary of restricted stock unit activity | ' | ||||||||||||||||||||||||||||||||
The following is a summary of RSU activity for the indicated periods: | |||||||||||||||||||||||||||||||||
Years Ended December 31, | |||||||||||||||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||||||||||||||
Number of | Weighted- | Weighted- | Aggregate | Number of | Weighted- | Weighted- | Aggregate | ||||||||||||||||||||||||||
Shares | Average Grant | average | Intrinsic | Shares | Average Grant | average | Intrinsic | ||||||||||||||||||||||||||
Date Fair | Remaining | Value, in | Date Fair | Remaining | Value, in | ||||||||||||||||||||||||||||
Value | Contractual | Thousands | Value | Contractual | Thousands | ||||||||||||||||||||||||||||
Term, in Years | Term, in Years | ||||||||||||||||||||||||||||||||
Outstanding, January 1 | 199,005 | $ | 2.78 | 0.16 | $ | 382 | - | $ | - | ||||||||||||||||||||||||
Granted | 1,578,373 | 1.16 | 829,269 | 2.78 | |||||||||||||||||||||||||||||
Released | (426,141 | ) | 1.83 | (607,206 | ) | 2.78 | |||||||||||||||||||||||||||
Forfeited/expired | (37,436 | ) | 1.19 | (23,058 | ) | 2.75 | |||||||||||||||||||||||||||
Outstanding, December 31 | 1,313,801 | $ | 1.19 | 1.85 | $ | 2,010 | 199,005 | $ | 2.78 | 0.16 | $ | 382 |
BENEFIT_PLANS_Tables
BENEFIT PLANS (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
BENEFIT PLANS [Abstract] | ' | ||||||||
Schedule of changes in the benefit obligations and fair value of assets | ' | ||||||||
The following tables summarize changes in the benefit obligation, the plan assets and the funded status of the pension benefit plan as well as the components of net periodic benefit costs, including key assumptions (in thousands). | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Change in projected benefit obligation: | |||||||||
Beginning benefit obligation | $ | 692 | $ | 450 | |||||
Service cost | 35 | 35 | |||||||
Interest cost | 16 | 10 | |||||||
Plan participants contributions | 21 | 14 | |||||||
Foreign exchange adjustments | 16 | 19 | |||||||
Actuarial loss (gain) | (132 | ) | 77 | ||||||
Transfer in | - | 87 | |||||||
Ending benefit obligation | $ | 648 | $ | 692 | |||||
Change in plan assets: | |||||||||
Beginning fair value of plan assets | $ | 440 | $ | 385 | |||||
Employer contributions | 21 | 14 | |||||||
Plan participants' contributions | 21 | 14 | |||||||
Foreign exchange adjustments | 14 | 12 | |||||||
Expected return on plan assets | 12 | (72 | ) | ||||||
Transfer in | - | 87 | |||||||
Ending fair value of plan assets | $ | 508 | $ | 440 | |||||
Benefits paid | $ | - | $ | - | |||||
Schedule of funding status | ' | ||||||||
The following table summarizes the funding status as of December 31, 2013 and 2012 (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Projected benefit obligation | $ | (648 | ) | $ | (692 | ) | |||
Fair value of plan assets | 508 | 440 | |||||||
Funded status of the plan at the end of the year, recorded as a long-term liability | $ | (140 | ) | $ | (252 | ) | |||
Schedule of net periodic benefit cost | ' | ||||||||
The amount that will be amortized from accumulated other comprehensive income, net of tax, into net periodic benefit cost in 2014 is $10,000. The following are the components of estimated net periodic benefit cost in 2014 (in thousands): | |||||||||
Year ending | |||||||||
December 31, | |||||||||
2014 | |||||||||
Service cost (net) | $ | 30 | |||||||
Interest cost | 14 | ||||||||
Expected return on plan assets | (11 | ) | |||||||
Amortization: | |||||||||
Actuarial gain | (10 | ) | |||||||
Net periodic benefit cost | $ | 23 | |||||||
The net periodic benefit cost for the plan included the following components (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Service cost (net) | $ | 35 | $ | 35 | |||||
Interest cost | 16 | 10 | |||||||
Net periodic benefit cost | $ | 51 | $ | 45 |
RESTRUCTURING_Tables
RESTRUCTURING (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
RESTRUCTURING [Abstract] | ' | ||||||||
Summary of restructuring activity | ' | ||||||||
The following is a summary of the restructuring activity (in thousands): | |||||||||
Year ending December 31, | |||||||||
2013 | 2012 | ||||||||
Beginning balance | $ | 168 | $ | 696 | |||||
Charges | 950 | 207 | |||||||
Uses and adjustments | (1,088 | ) | (735 | ) | |||||
Ending balance | $ | 30 | $ | 168 |
INCOME_TAXES_Tables
INCOME TAXES (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
INCOME TAXES [Abstract] | ' | ||||||||
Schedule of components of net loss before income taxes | ' | ||||||||
The components of loss before provision for income taxes are as follows (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
United States | $ | 1,480 | $ | (6,156 | ) | ||||
International | (3,376 | ) | (767 | ) | |||||
Loss before provision for income taxes | $ | (1,896 | ) | $ | (6,923 | ) | |||
Schedule of components of provision for (benefit) from income taxes | ' | ||||||||
Components of provision for income taxes are as follows (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Current | |||||||||
United States | $ | 37 | $ | 115 | |||||
International | - | - | |||||||
State | 13 | 2 | |||||||
Total | 50 | 117 | |||||||
Deferred | |||||||||
United States | - | (36 | ) | ||||||
International | - | - | |||||||
Total | - | (36 | ) | ||||||
Provision for income taxes | $ | 50 | $ | 81 | |||||
Schedule of effective income tax rate reconciliation | ' | ||||||||
Provision for income taxes differs from the amount computed by applying the statutory United States federal income tax rate to loss before taxes as follows: | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
Income tax at the federal statutory rate | (34.00 | )% | (34.00 | )% | |||||
State tax net of federal benefit | 0.71 | % | 0.02 | % | |||||
Foreign tax rate differential | 60.55 | % | 4.19 | % | |||||
Permanent items and other | 1.93 | % | 1.67 | % | |||||
Losses not benefited | (26.55 | )% | 29.29 | % | |||||
Effective tax rate | 2.64 | % | 1.17 | % | |||||
Components of net deferred tax assets and liabilities | ' | ||||||||
The components of the net deferred tax assets and liabilities are as follows (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Deferred tax asset (liability), net | |||||||||
Net operating losses | $ | 20,398 | $ | 21,530 | |||||
Tax credits | 3,022 | 3,022 | |||||||
Accrued and reserves | 1,872 | 2,139 | |||||||
Fixed assets | 966 | 847 | |||||||
Other | 2,176 | 1,506 | |||||||
Total deferred tax asset | 28,434 | 29,044 | |||||||
Valuation allowance | (27,587 | ) | (27,898 | ) | |||||
Net deferred tax asset | 847 | 1,146 | |||||||
Pension other comprehensive income | (40 | ) | - | ||||||
Intangible assets | (847 | ) | (1,146 | ) | |||||
Deferred tax liability | (887 | ) | (1,146 | ) | |||||
Net deferred tax asset (liability) | $ | (40 | ) | $ | - | ||||
Schedule of unrecognized tax benefits | ' | ||||||||
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows (in thousands): | |||||||||
Total | |||||||||
Balance at December 31, 2011 | $ | 2,065 | |||||||
Increases related to current year tax positions | 364 | ||||||||
Increases related to prior year tax positions | 99 | ||||||||
Decreases related to prior year tax positions | (5 | ) | |||||||
Balance at December 31, 2012 | 2,523 | ||||||||
Increases related to current year tax positions | 205 | ||||||||
Increases related to prior year tax positions | 37 | ||||||||
Decreases related to prior year tax positions | - | ||||||||
Balance at December 31, 2013 | $ | 2,765 |
NET_LOSS_PER_SHARE_Tables
NET LOSS PER SHARE (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
NET LOSS PER SHARE [Abstract] | ' | ||||||||
Antidilutive Securities Excluded from Computation of Earnings Per Share | ' | ||||||||
The following table summarizes total securities outstanding which were not included in the calculation of diluted net loss per share because to do so would have been anti-dilutive: | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Stock options and restricted stock units | 11,620,472 | 10,299,434 | |||||||
Common stock warrants | 1,468,239 | 1,810,595 | |||||||
Total | 13,088,711 | 12,110,029 |
SEGMENT_AND_GEOGRAPHIC_INFORMA1
SEGMENT AND GEOGRAPHIC INFORMATION (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
SEGMENT AND GEOGRAPHIC INFORMATION [Abstract] | ' | ||||||||
Revenue by geographic region and long lived assets by country | ' | ||||||||
The following table summarizes revenue by geographic region (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
North America | $ | 7,943 | $ | 11,298 | |||||
Asia | 7,700 | 9,731 | |||||||
Europe | 12,306 | 15,458 | |||||||
Other | 977 | 247 | |||||||
$ | 28,926 | $ | 36,734 | ||||||
The following table summarizes long-lived assets by country (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
United States | $ | 2,004 | $ | 2,595 | |||||
Switzerland | 995 | 1,984 | |||||||
$ | 2,999 | $ | 4,579 | ||||||
Revenue by product line | ' | ||||||||
The following table summarizes revenue by product line (in thousands): | |||||||||
Years ended December 31, | |||||||||
2013 | 2012 | ||||||||
HSC | $ | 19,886 | $ | 21,307 | |||||
Industrial | 9,040 | 14,549 | |||||||
Government | - | 878 | |||||||
Total revenue | $ | 28,926 | $ | 36,734 |
COMMITMENTS_AND_CONTINGENCIES_
COMMITMENTS AND CONTINGENCIES (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
COMMITMENTS AND CONTINGENCIES [Abstract] | ' | ||||||||
Aggregate non-cancelable future minimum rental payments | ' | ||||||||
Aggregate non-cancelable future minimum lease payments under capital and operating leases are as follows (in thousands): | |||||||||
Capital Leases | Operating Leases | ||||||||
Years ending December 31, | Minmum lease payments | Minmum lease payments | |||||||
2014 | $ | 310 | $ | 643 | |||||
2015 | 4 | 351 | |||||||
2016 | 3 | 339 | |||||||
2017 and beyond | 3 | 57 | |||||||
Total minimum lease payments | 320 | $ | 1,390 | ||||||
Less: Amount representing interest | (26 | ) | |||||||
Total capital lease obligations | 294 | ||||||||
Less: current portion | (284 | ) | |||||||
Long-term portion of capital lease obligations | $ | 10 | |||||||
Gross and net book value of capital lease assets | ' | ||||||||
The gross and net book value of the fixed assets purchased under capital lease was as follows (in thousands): | |||||||||
As of the years December 31, | |||||||||
2013 | 2012 | ||||||||
Acquired cost | $ | 1,666 | $ | 1,653 | |||||
Accumulated amortization | (1,378 | ) | (1,047 | ) | |||||
Net book value | $ | 288 | $ | 606 | |||||
Summary of changes in warranty accrual | ' | ||||||||
The table below summarizes the movement in the warranty accrual, which is included as a component of other current liabilities, for the years ended December 31, 2013 and 2012 (in thousands): | |||||||||
December 31, | |||||||||
2013 | 2012 | ||||||||
Balance at January 1 | $ | 612 | $ | 296 | |||||
Warranties accrued | 510 | 1,328 | |||||||
Warranties settled or reversed | (792 | ) | (1,012 | ) | |||||
Balance at December 31 | $ | 330 | $ | 612 |
ORGANIZATION_AND_BASIS_OF_PRES3
ORGANIZATION AND BASIS OF PRESENTATION (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
OperatingUnit | ||
ProductLine | ||
Organization [Abstract] | ' | ' |
Number of product lines | 2 | ' |
Revenue Recognition [Line Items] | ' | ' |
Percentage of gross margin at which revenue from development projects are recorded (in hundredths) | 100.00% | ' |
Period of stock rotation | '6 months | ' |
Reserve for stock rotations | $151,000 | $65,000 |
Accounts Receivable and Allowance for Doubtful Accounts [Abstract] | ' | ' |
Accounts receivable, net | 5,021,000 | 5,056,000 |
Allowance for doubtful accounts | 220,000 | 337,000 |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Number of operating units | 1 | ' |
Impairment of goodwill | 0 | 0 |
Restricted cash | 284,000 | 282,000 |
Restricted cash in satisfaction of the letter of credit provisions | 151,000 | ' |
Restricted cash held in escrow account | 58,000 | 56,000 |
Restricted cash held with silicon valley bank | 75,000 | ' |
Foreign currency transaction gain (loss) | -11,000 | 41,000 |
Product Warranty [Abstract] | ' | ' |
Warranty term | '1 year | ' |
Advertising expense | 46,000 | 66,000 |
Accumulated Other Comprehensive Income Loss [Line Items] | ' | ' |
Accumulated other comprehensive income | 490,000 | 298,000 |
Foreign currency translation adjustment, net of tax [Member] | ' | ' |
Accumulated Other Comprehensive Income Loss [Line Items] | ' | ' |
Accumulated other comprehensive income | 353,000 | 262,000 |
Change in pension liability in connection with actuarial gain, net of tax [Member] | ' | ' |
Accumulated Other Comprehensive Income Loss [Line Items] | ' | ' |
Accumulated other comprehensive income | $137,000 | $36,000 |
Stock Options [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Vesting term | '4 years | ' |
Restricted Stock [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Vesting term | '1 year | ' |
Order Backlog [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '1 year | ' |
Trade Names [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '10 years | ' |
Accounts Receivable [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Number of customers | 2 | 1 |
Accounts Receivable [Member] | Customer One [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk percentage (in hundredths) | 29.00% | 31.00% |
Accounts Receivable [Member] | Customer Two [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk percentage (in hundredths) | 17.00% | ' |
Total Revenue [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Number of customers | 1 | 2 |
Total Revenue [Member] | Customer One [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk percentage (in hundredths) | 33.00% | 22.00% |
Total Revenue [Member] | Customer Two [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk percentage (in hundredths) | ' | 12.00% |
Minimum [Member] | ' | ' |
Revenue Recognition [Line Items] | ' | ' |
Stock rotation privileges specified as percentage of net sales | 5.00% | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Estimated useful life | '1 year | ' |
Minimum [Member] | Restricted Stock [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Vesting term | '1 year | ' |
Minimum [Member] | Existing Technology [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '6 years | ' |
Minimum [Member] | Patents [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '5 years | ' |
Minimum [Member] | Customer Relationships [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '3 years | ' |
Minimum [Member] | Leasehold Improvements [Member] | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Estimated useful life | '1 year | ' |
Maximum [Member] | ' | ' |
Revenue Recognition [Line Items] | ' | ' |
Stock rotation privileges specified as percentage of net sales | 10.00% | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Estimated useful life | '7 years | ' |
Maximum [Member] | Restricted Stock [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Vesting term | '4 years | ' |
Maximum [Member] | Existing Technology [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '7 years | ' |
Maximum [Member] | Patents [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '16 years | ' |
Maximum [Member] | Customer Relationships [Member] | ' | ' |
Acquired Finite-Lived Intangible Assets [Line Items] | ' | ' |
Acquired intangible asset useful life | '8 years | ' |
Maximum [Member] | Leasehold Improvements [Member] | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Estimated useful life | '5 years | ' |
BALANCE_SHEET_COMPONENTS_Detai
BALANCE SHEET COMPONENTS (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
BALANCE SHEET COMPONENTS [Abstract] | ' | ' |
Accounts receivable, gross | $5,241,000 | $5,393,000 |
Allowance for doubtful accounts | -220,000 | -337,000 |
Accounts receivable, net | 5,021,000 | 5,056,000 |
Property and equipment [Line Items] | ' | ' |
Property and equipment, gross | 15,869,000 | 15,297,000 |
Accumulated depreciation and amortization | -12,870,000 | -10,718,000 |
Property and equipment, net | 2,999,000 | 4,579,000 |
Depreciation and amortization expense related to property and equipment | 2,200,000 | 2,700,000 |
Amortization | 660,000 | 388,000 |
Inventory, net [Abstract] | ' | ' |
Raw materials | 2,103,000 | 2,290,000 |
Work in process | 780,000 | 687,000 |
Finished goods | 1,734,000 | 1,134,000 |
Inventories | 4,617,000 | 4,111,000 |
Other current liabilities [Abstract] | ' | ' |
Amounts billed to the U.S. government in excess of approved rates | 191,000 | 191,000 |
Warrants liability | 330,000 | 612,000 |
Customer deposits | 313,000 | 432,000 |
Capital lease obligation, current portion | 284,000 | 324,000 |
Restructuring liabilities | 30,000 | 168,000 |
Sales return reserve | 151,000 | 65,000 |
Other | 1,447,000 | 1,288,000 |
Other current liabilities | 2,746,000 | 3,080,000 |
Minimum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '1 year | ' |
Maximum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '7 years | ' |
Network and Laboratory Equipment [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Property and equipment, gross | 11,250,000 | 10,654,000 |
Network and Laboratory Equipment [Member] | Minimum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '3 years | ' |
Network and Laboratory Equipment [Member] | Maximum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '5 years | ' |
Computer Software and Equipment [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Property and equipment, gross | 3,928,000 | 3,747,000 |
Computer Software and Equipment [Member] | Minimum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '2 years | ' |
Computer Software and Equipment [Member] | Maximum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '3 years | ' |
Furniture And Fixtures [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Property and equipment, gross | 176,000 | 176,000 |
Furniture And Fixtures [Member] | Minimum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '3 years | ' |
Furniture And Fixtures [Member] | Maximum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '7 years | ' |
Office Equipment [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Property and equipment, gross | 137,000 | 106,000 |
Office Equipment [Member] | Minimum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '3 years | ' |
Office Equipment [Member] | Maximum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '5 years | ' |
Leasehold Improvements [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Property and equipment, gross | 378,000 | 378,000 |
Leasehold Improvements [Member] | Minimum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '1 year | ' |
Leasehold Improvements [Member] | Maximum [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Life | '5 years | ' |
Construction-In-Progress [Member] | ' | ' |
Property and equipment [Line Items] | ' | ' |
Property and equipment, gross | $0 | $236,000 |
FAIR_VALUE_MEASUREMENTS_Detail
FAIR VALUE MEASUREMENTS (Details) (USD $) | 0 Months Ended | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||||||||||||
In Thousands, except Share data, unless otherwise specified | Dec. 24, 2013 | Jul. 07, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 |
Liability Warrants [Member] | Liability Warrants [Member] | Bridge Bank Warrant [Member] | Bridge Bank Warrant [Member] | Bridge Bank Warrant [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Carrying Value [Member] | Carrying Value [Member] | Carrying Value [Member] | Carrying Value [Member] | Carrying Value [Member] | Carrying Value [Member] | ||||||
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] | Significant Other Observable Inputs (Level 2) [Member] | Significant Other Observable Inputs (Level 2) [Member] | Significant Other Observable Inputs (Level 2) [Member] | Significant Other Observable Inputs (Level 2) [Member] | Significant Other Observable Inputs (Level 2) [Member] | Significant Other Observable Inputs (Level 2) [Member] | Significant Unobservable Inputs (Level 3) [Member] | Significant Unobservable Inputs (Level 3) [Member] | Significant Unobservable Inputs (Level 3) [Member] | Significant Unobservable Inputs (Level 3) [Member] | Significant Unobservable Inputs (Level 3) [Member] | Significant Unobservable Inputs (Level 3) [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | Recurring [Member] | |||||||||||
Money Market Funds [Member] | Money Market Funds [Member] | Liability Warrants [Member] | Liability Warrants [Member] | Money Market Funds [Member] | Money Market Funds [Member] | Liability Warrants [Member] | Liability Warrants [Member] | Money Market Funds [Member] | Money Market Funds [Member] | Liability Warrants [Member] | Liability Warrants [Member] | Money Market Funds [Member] | Money Market Funds [Member] | Liability Warrants [Member] | Liability Warrants [Member] | |||||||||||||||||||
Cash equivalents [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1,356 | $2,856 | $1,356 | $2,856 | ' | ' | $0 | $0 | $0 | $0 | ' | ' | $0 | $0 | $0 | $0 | ' | ' | $1,356 | $2,856 | $1,356 | $2,856 | ' | ' |
Current liabilities [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Liability warrants | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | 0 | 0 | ' | ' | ' | ' | 15 | 24 | ' | ' | ' | ' | 15 | 24 |
Class of Warrant or Right [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Additional equity shares issued (in shares) | 9,573,750 | 2,760,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share price of additional equity offering (in dollars per share) | $1.42 | $1.75 | $1.53 | $1.92 | $1.75 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair value assumptions | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock price (in dollars per share) | $1.42 | $1.75 | $1.53 | $1.92 | $1.75 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Strike price (in dollars per share) | ' | ' | $2.51 | $3.32 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expected life | ' | ' | '3 years 6 months 18 days | '4 years 6 months 18 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Risk-free interest rate (in hundredths) | ' | ' | 1.30% | 0.62% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Volatility (in hundredths) | ' | ' | 65.00% | 85.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair value per share (in dollars per share) | ' | ' | $0.52 | $1.03 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Warrants subject to liability accounting [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Holder | ' | ' | ' | ' | ' | ' | ' | 'Bridge Bank | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Original warrants (in shares) | ' | ' | ' | ' | ' | ' | ' | 20,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Adjusted warrants (in shares) | ' | ' | 1,468,239 | 1,810,595 | ' | ' | ' | 29,115 | 22,671 | 20,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Grant date | ' | ' | ' | ' | ' | ' | ' | 7-Apr-10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Expiration date | ' | ' | ' | ' | ' | ' | ' | 7-Jul-17 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Price per share (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | $2.51 | ' | $3.22 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair value | ' | ' | 330 | 612 | ' | 15 | 24 | 15 | 24 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Exercise of warrants | ' | ' | ' | ' | ' | 0 | 0 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Change in fair value | ' | ' | ' | ' | ' | -9 | 3 | -9 | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Related agreement | ' | ' | ' | ' | ' | ' | ' | 'Credit Agreement | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Change in fair value of Level 3 liability warrants [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair value, beginning of period | ' | ' | 612 | ' | ' | 24 | 21 | 24 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Exercise of warrants | ' | ' | ' | ' | ' | 0 | 0 | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Change in fair value | ' | ' | ' | ' | ' | -9 | 3 | -9 | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair value, end of period | ' | ' | $330 | $612 | ' | $15 | $24 | $15 | $24 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
INTANGIBLE_ASSETS_AND_GOODWILL2
INTANGIBLE ASSETS AND GOODWILL (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross intangible asset | $8,908 | $8,908 |
Accumulated amortization | -5,621 | -4,638 |
Net intangible asset | 3,287 | 4,270 |
Amortization of intangible assets | 983 | 1,011 |
Cost of Revenue [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Amortization of intangible assets | 484 | 489 |
Selling, General and Administrative Expenses [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Amortization of intangible assets | 499 | 522 |
Customer Relationships [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross intangible asset | 3,277 | 3,277 |
Accumulated amortization | -1,697 | -1,274 |
Net intangible asset | 1,580 | 2,003 |
Existing Technology [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross intangible asset | 3,783 | 3,783 |
Accumulated amortization | -2,473 | -2,065 |
Net intangible asset | 1,310 | 1,718 |
Order Backlog [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross intangible asset | 732 | 732 |
Accumulated amortization | -732 | -732 |
Net intangible asset | 0 | 0 |
Patents [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross intangible asset | 457 | 457 |
Accumulated amortization | -397 | -321 |
Net intangible asset | 60 | 136 |
Trade Name [Member] | ' | ' |
Finite-Lived Intangible Assets [Line Items] | ' | ' |
Gross intangible asset | 659 | 659 |
Accumulated amortization | -322 | -246 |
Net intangible asset | $337 | $413 |
INTANGIBLE_ASSETS_AND_GOODWILL3
INTANGIBLE ASSETS AND GOODWILL, Schedule of Acquired Finite-Lived Intangible Asset by Major Class (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Future amortization expense [Abstract] | ' | ' |
2014 | $893,000 | ' |
2015 | 893,000 | ' |
2016 | 869,000 | ' |
2017 | 487,000 | ' |
2018 | 145,000 | ' |
Total | 3,287,000 | ' |
Goodwill [Line Items] | ' | ' |
Goodwill related to acquisition | 9,860,000 | 9,860,000 |
Impairment of goodwill | 0 | 0 |
ChipX [Member] | ' | ' |
Goodwill [Line Items] | ' | ' |
Goodwill related to acquisition | 9,900,000 | ' |
Endwave Corporation [Member] | ' | ' |
Goodwill [Line Items] | ' | ' |
Goodwill related to acquisition | $9,900,000 | ' |
CREDIT_FACILITIES_Details
CREDIT FACILITIES (Details) (Line of Credit - Silicon Valley Bank [Member], USD $) | 12 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2013 |
Line of Credit - Silicon Valley Bank [Member] | ' |
Line of Credit Facility [Line Items] | ' |
Maximum borrowing capacity | $7 |
Borrowing capacity with reference to accounts receivable | 3.5 |
Borrowing base percentage used for maximum borrowing capacity (in hundredths) | 80.00% |
Borrowing capacity without reference to accounts receivable | 3.5 |
Amount outstanding | $0 |
Number of business days to repay interest on borrowings unrelated to accounts receivable balances | '3 days |
STOCKHOLDERS_EQUITY_Details
STOCKHOLDERS' EQUITY (Details) (USD $) | 3 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | |||||||||||
Jul. 01, 2012 | Dec. 31, 2013 | Dec. 31, 2010 | Dec. 24, 2013 | Dec. 31, 2012 | Jul. 07, 2010 | Dec. 31, 2009 | Dec. 31, 2008 | Dec. 31, 2013 | 22-May-12 | Mar. 23, 2012 | Dec. 31, 2012 | Mar. 23, 2012 | Mar. 23, 2012 | Dec. 31, 2008 | Dec. 31, 2013 | Dec. 31, 2013 | |
Preferred Share Purchase Right [Member] | Modified Dutch Auction Tender Offer [Member] | Modified Dutch Auction Tender Offer [Member] | Modified Dutch Auction Tender Offer [Member] | Modified Dutch Auction Tender Offer [Member] | Modified Dutch Auction Tender Offer [Member] | Series A Junior Preferred Stock [Member] | Public offering [Member] | Over allotment [Member] | |||||||||
Minimum [Member] | Maximum [Member] | ||||||||||||||||
Subsidiary, Sale of Stock [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Date of transaction | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 19-Dec-13 | 24-Dec-13 |
Number of shares issued in transaction (in shares) | ' | 9,573,750 | 2,760,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 8,325,000 | 1,248,750 |
Par value on common stock in public offering (in dollars per share) | ' | $0.00 | ' | ' | $0.00 | ' | $0.00 | $0.00 | ' | ' | ' | ' | ' | ' | ' | $0.00 | ' |
Public offering price per share (in dollars per share) | ' | $1.42 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.42 | ' |
Proceeds from the sale of stock | ' | $12,500,000 | $4,800,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $12,300,000 | ' |
Costs related to public offering | ' | 250,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Modified Dutch auction tender offer [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Announcement to purchase of common stock | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,000,000 | ' | ' | ' | ' | ' | ' |
Stock repurchased, average cost per share (in dollar per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2.85 | $2.85 | $3.10 | ' | ' | ' |
Number of shares of common stock repurchased (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | 701,754 | ' | ' | ' | ' | ' | ' | ' |
Common stock repurchased | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,200,000 | ' | ' | ' | ' | ' | ' | ' |
Investment banking, registration and other transaction costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | 209,000 | ' | ' | ' | ' | ' | ' | ' |
Preferred stock, authorized (in shares) | ' | 1,000,000 | ' | ' | 1,000,000 | ' | ' | 1,000,000 | ' | ' | ' | ' | ' | ' | 300,000 | ' | ' |
Common and preferred stock [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common stock, authorized (in shares) | ' | 50,000,000 | ' | ' | 50,000,000 | ' | ' | 50,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common stock, par value (in dollars per share) | ' | $0.00 | ' | ' | $0.00 | ' | $0.00 | $0.00 | ' | ' | ' | ' | ' | ' | ' | $0.00 | ' |
Preferred stock, par value (in dollars per share) | ' | $0.00 | ' | ' | $0.00 | ' | ' | $0.00 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred stock, issued (in shares) | ' | 0 | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred stock, outstanding (in shares) | ' | 0 | ' | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred stock, voting rights | ' | 'Each share of preferred stock has voting rights equal to one thousand shares of common stock. | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common stock dividends, number of preferred stock purchase rights per share (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | 1,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Fractional share of preferred stock each preferred share purchase right is entitled to (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | 1,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Minimum ownership percentage of beneficial owner for exercisability of rights to purchase preferred stock to be triggered (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' |
Minimum percentage of additional purchase of outstanding shares by existing owner of 10 percent or more for exercisability of rights to purchase preferred stock to be triggered (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | 1.00% | ' | ' | ' | ' | ' | ' | ' | ' |
Exercise price per share (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | $8.50 | ' | ' | ' | ' | ' | ' | ' | ' |
Share price (in dollars per share) | ' | $1.53 | $1.75 | $1.42 | $1.92 | $1.75 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Proceeds from public offering of stock, gross | $13,600,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
STOCKHOLDERS_EQUITY_Warrants_D
STOCKHOLDERS' EQUITY, Warrants (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Warrants outstanding (in shares) | 1,468,239 | 1,810,595 | ' |
Number of warrants expired (in shares) | 348,800 | ' | ' |
Warrants exercised (in shares) | ' | 137,500 | ' |
Common stock shares issued for warrants exercised (in shares) | 0 | 14,158 | ' |
Alliance Advisors LLC [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $1.75 | ' | ' |
Investment Warrants Expiration Date | 20-Jul-14 | ' | ' |
Warrants outstanding (in shares) | 25,000 | 25,000 | ' |
Number of warrants expired (in shares) | 0 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
Bridge Bank Warrant [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $2.51 | ' | $3.22 |
Investment Warrants Expiration Date | 7-Jul-17 | ' | ' |
Warrants outstanding (in shares) | 29,115 | 22,671 | 20,000 |
Number of warrants expired (in shares) | 0 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
Number of additional warrants issued (in shares) | 6,444 | 2,671 | ' |
Warrants issued to PIPE investors [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $2.50 | ' | ' |
Investment Warrants Expiration Date | 28-Dec-13 | ' | ' |
Warrants outstanding (in shares) | 0 | 242,500 | ' |
Number of warrants expired (in shares) | 242,500 | ' | ' |
Warrants exercised (in shares) | ' | 137,500 | ' |
Sandgrain Securities Inc. [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $2.50 | ' | ' |
Investment Warrants Expiration Date | 28-Dec-13 | ' | ' |
Warrants outstanding (in shares) | 0 | 4,000 | ' |
Number of warrants expired (in shares) | 4,000 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
Warrants issued to investors in connection with the Lumera Merger I [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $24 | ' | ' |
Investment Warrants Expiration Date | 21-Feb-13 | ' | ' |
Warrants outstanding (in shares) | 0 | 22,500 | ' |
Number of warrants expired (in shares) | 22,500 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
Warrants issued to investors in connection with the Lumera Merger II [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $6.08 | ' | ' |
Investment Warrants Expiration Date | 16-Jan-14 | ' | ' |
Warrants outstanding (in shares) | 284,999 | 284,999 | ' |
Number of warrants expired (in shares) | 0 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
Silicon Valley Bank I [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $0.73 | ' | ' |
Investment Warrants Expiration Date | 5-Oct-17 | ' | ' |
Warrants outstanding (in shares) | 4,125 | 4,125 | ' |
Number of warrants expired (in shares) | 0 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
Silicon Valley Bank II [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $4 | ' | ' |
Investment Warrants Expiration Date | 23-Apr-17 | ' | ' |
Warrants outstanding (in shares) | 125,000 | 125,000 | ' |
Number of warrants expired (in shares) | 0 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
Warrants issued to GigOptix LLC executives in connections with the Lumera Merger [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $6.08 | ' | ' |
Investment Warrants Expiration Date | 16-Jul-13 | ' | ' |
Warrants outstanding (in shares) | 0 | 79,800 | ' |
Number of warrants expired (in shares) | 79,800 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
DBSI Settlement Warrant I [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $2.60 | ' | ' |
Investment Warrants Expiration Date | 8-Apr-14 | ' | ' |
Warrants outstanding (in shares) | 500,000 | 500,000 | ' |
Number of warrants expired (in shares) | 0 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
DBSI Settlement Warrant II [Member] | ' | ' | ' |
Class of Warrant or Right [Line Items] | ' | ' | ' |
Exercise price per share (in dollars per share) | $3 | ' | ' |
Investment Warrants Expiration Date | 8-Apr-15 | ' | ' |
Warrants outstanding (in shares) | 500,000 | 500,000 | ' |
Number of warrants expired (in shares) | 0 | ' | ' |
Warrants exercised (in shares) | ' | 0 | ' |
STOCKHOLDERS_EQUITY_Sharebased
STOCKHOLDERS' EQUITY, Share-based Compensation Arrangements by Share-based Payment Award (Details) (USD $) | Dec. 31, 2013 | Dec. 24, 2013 | Dec. 31, 2012 | Dec. 31, 2010 | Jul. 07, 2010 | Mar. 17, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Mar. 17, 2010 | Dec. 31, 2013 | Mar. 17, 2010 | Mar. 31, 2013 | Apr. 03, 2011 | Apr. 03, 2012 | Apr. 02, 2011 | Mar. 31, 2013 | Apr. 03, 2012 | Mar. 17, 2010 | Mar. 17, 2010 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2009 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 |
Stock Options [Member] | Stock Options [Member] | Stock Options [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock [Member] | Restricted Stock Units (RSUs) [Member] | Restricted Stock Units (RSUs) [Member] | Stock Options with Vesting over Specified Period of Time [Member] | Stock Options with Vesting over Specified Period of Time [Member] | Stock Options with Market Conditions [Member] | Stock Options with Market Conditions [Member] | Stock Options with Market Conditions [Member] | Stock Options with Market Conditions [Member] | Stock Options with Market Conditions [Member] | Stock Options with Market Conditions, Nonvested [Member] | Stock Options with Market Conditions, Nonvested [Member] | Employees and Consultants [Member] | Board Members [Member] | 2007 Equity Incentive Plan [Member] | 2007 Equity Incentive Plan [Member] | 2007 Equity Incentive Plan [Member] | 2007 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | 2008 Equity Incentive Plan [Member] | Lumera 2000 and 2004 Stock Option Plan [Member] | ||||||
Minimum [Member] | Maximum [Member] | Stock Options [Member] | Stock Options [Member] | Stock Options [Member] | Warrant [Member] | Restricted Stock [Member] | Maximum [Member] | Stock Options [Member] | Stock Options [Member] | Restricted Stock Units (RSUs) [Member] | 10% Stockholder [Member] | ||||||||||||||||||||||||||
Minimum [Member] | Stock Options [Member] | ||||||||||||||||||||||||||||||||||||
Maximum [Member] | |||||||||||||||||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of shares authorized (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 632,500 | ' | ' | ' | 15,021,253 | 13,910,965 | 2,500,000 | 21,000,000 | 11,130,371 | ' | 2,784,883 | ' | ' |
Number of shares available for grant (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,085,195 | ' | ' | ' | ' | ' | ' | ' |
Automatic annual increase in shares authorized | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 'The lesser of (i) 5% of the number of shares of common stock outstanding as of the Company's immediately preceding fiscal year, or (ii) a number of shares determined by the Board of Directors. | ' | ' | ' | ' | ' | ' | ' | ' |
Automatic increase in number of shares reserved for future issuance (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,110,288 | 1,077,286 | ' | ' | ' | ' | ' | ' | ' |
Exercise price of stock options as percentage of fair market value on date of grant (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 100.00% | ' | 110.00% | ' |
Vesting period | ' | ' | ' | ' | ' | ' | '4 years | ' | '1 year | '1 year | '4 years | ' | ' | ' | '4 years | '4 years | '2 years | '1 year | ' | ' | '3 years | ' | ' | ' | ' | '4 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cliff vesting per year (in hundredths) | ' | ' | ' | ' | ' | ' | ' | 25.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Life from date of grant | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' |
Stock options cancelled (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 472,400 | ' | ' | 236,200 | ' | ' | ' | ' | 864 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of options outstanding (in shares) | ' | ' | ' | ' | ' | ' | 10,306,671 | 10,100,429 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 414,936 | ' | 9,807,431 | ' | ' | ' | ' | ' | ' | ' | ' | 75,165 |
Warrants outstanding (in shares) | 1,468,239 | ' | 1,810,595 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 4,125 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Percentage of outstanding common stock (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5.00% | ' | ' | ' | ' | ' | ' | ' | ' |
Merger conversion ratio (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.13% |
Total grant-date fair value | ' | ' | ' | ' | ' | ' | $436,000 | $4,800,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restricted stock units total grant date fair value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,800,000 | 2,300,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Unrecognized compensation expense | ' | ' | ' | ' | ' | ' | 3,900,000 | ' | ' | ' | ' | 1,300,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average period of recognition for unrecognized compensation cost | ' | ' | ' | ' | ' | ' | '2 years 0 months 25 days | ' | ' | ' | ' | '1 year 10 months 6 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Options granted (in shares) | ' | ' | ' | ' | ' | 2,382,000 | 689,010 | 2,771,533 | ' | ' | ' | ' | ' | 1,181,000 | ' | 1,201,000 | ' | ' | ' | ' | ' | ' | 2,292,000 | 90,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, granted (in dollars per shares) | ' | ' | ' | ' | ' | $1.95 | $0.92 | $2.64 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Average share price (in dollars per share) | ' | ' | ' | ' | ' | ' | $2.34 | $2.42 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3.01 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Average price per share requirement (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3.50 | $2.50 | ' | $5 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average grant date fair value (in dollars per share) | ' | ' | ' | ' | ' | ' | $0.63 | $1.74 | ' | ' | ' | ' | ' | ' | ' | ' | $1.01 | $1.05 | ' | ' | $1.01 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total expense associated options | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 477,000 | 496,000 | ' | ' | 239,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock price (in dollars per share) | $1.53 | $1.42 | $1.92 | $1.75 | $1.75 | ' | $1.92 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock options activity, number of shares [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding, beginning of year (in shares) | ' | ' | ' | ' | ' | ' | 10,100,429 | 8,495,725 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9,807,431 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Granted (in shares) | ' | ' | ' | ' | ' | 2,382,000 | 689,010 | 2,771,533 | ' | ' | ' | ' | ' | 1,181,000 | ' | 1,201,000 | ' | ' | ' | ' | ' | ' | 2,292,000 | 90,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Exercised (in shares) | ' | ' | ' | ' | ' | ' | -12,221 | -230,466 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited/Expired (in shares) | ' | ' | ' | ' | ' | ' | -470,547 | -936,363 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding, ending balance (in shares) | ' | ' | ' | ' | ' | ' | 10,306,671 | 10,100,429 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 414,936 | ' | 9,807,431 | ' | ' | ' | ' | ' | ' | ' | ' | 75,165 |
Vested and exercisable and expected to vest (in shares) | ' | ' | ' | ' | ' | ' | 10,101,382 | 9,512,994 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Vested and exercisable (in shares) | ' | ' | ' | ' | ' | ' | 7,297,096 | 5,004,706 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock option activity, weighted-average exercise price [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, beginning balance (in dollars per shares) | ' | ' | ' | ' | ' | ' | $2.42 | $2.58 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3.01 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, granted (in dollars per shares) | ' | ' | ' | ' | ' | $1.95 | $0.92 | $2.64 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, exercised (in dollars per shares) | ' | ' | ' | ' | ' | ' | $1.09 | $1.73 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, forfeited/expired (in dollars per shares) | ' | ' | ' | ' | ' | ' | $2.12 | $4.65 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, ending balance (in dollars per shares) | ' | ' | ' | ' | ' | ' | $2.34 | $2.42 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3.01 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, vested and expected to vest (in dollars per share) | ' | ' | ' | ' | ' | ' | $2.34 | $2.43 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average exercise price, exercisable (in dollars per share) | ' | ' | ' | ' | ' | ' | $2.39 | $2.32 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term, ending balance | ' | ' | ' | ' | ' | ' | '6 years 11 months 16 days | '7 years 9 months 22 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term, expected to vest | ' | ' | ' | ' | ' | ' | '6 years 11 months 5 days | '7 years 9 months 7 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted average remaining contractual term, exercisable | ' | ' | ' | ' | ' | ' | '6 years 5 months 19 days | '6 years 11 months 1 day | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate Intrinsic Value [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value, exercised | ' | ' | ' | ' | ' | ' | 3,000 | 178,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value, outstanding | ' | ' | ' | ' | ' | ' | 1,405,000 | 1,874,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value, vested and expected to vest | ' | ' | ' | ' | ' | ' | 1,379,000 | 1,868,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value, exercisable | ' | ' | ' | ' | ' | ' | 1,017,000 | 1,809,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restricted stock activity, number of shares [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding, beginning of period (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 199,005 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Granted (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,578,373 | 829,269 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Released (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -426,141 | -607,206 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited/expired (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -37,436 | -23,058 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding, end of period (in shaers) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,313,801 | 199,005 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restricted stock activity, Weighted Average Grant Date Fair Value [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding, beginning of period (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $2.78 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Granted (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.16 | $2.78 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Released (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.83 | $2.78 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Forfeited/expired (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.19 | $2.75 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Outstanding, end of period (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1.19 | $2.78 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restricted stock activity, Weighted-average Remaining Contractual Term, Years [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Weighted-average remaining contractual term | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '1 year 10 months 6 days | '0 years 1 month 28 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Restricted stock activity, Aggregate Intrinsic Value [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value outstanding beginning balance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 382,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value outstanding ending balance | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 2,010,000 | 382,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Aggregate intrinsic value of vested and expected to vest awards | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 652,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares withheld to satisfy minimum tax obligation (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150,242 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Amount withheld to satisfy minimum tax obligation | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $194,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
STOCKHOLDERS_EQUITY_Shares_Aut
STOCKHOLDERS' EQUITY, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details) (Stock Options [Member], USD $) | 12 Months Ended |
Dec. 31, 2013 | |
Range $0.73 - $1.83 [Member] | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract] | ' |
Range of Exercise Prices, Lower Range Limit (in dollars per share) | $0.73 |
Range of Exercise Prices, Upper Range Limit (in dollars per share) | $1.83 |
Options Outstanding, Number of Shares Outstanding (in shares) | 2,836,418 |
Options Outstanding ,Weighted Average Remaining Contractual Life (in years) | '6 years 0 months 11 days |
Options Outstanding ,Weighted Average Exercise Price (in dollars per share) | $1.04 |
Options Exercisable, Number of Shares Exercisable (in shares) | 2,075,768 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $1.05 |
Range $1.86 - $2.40 [Member] | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract] | ' |
Range of Exercise Prices, Lower Range Limit (in dollars per share) | $1.86 |
Range of Exercise Prices, Upper Range Limit (in dollars per share) | $2.40 |
Options Outstanding, Number of Shares Outstanding (in shares) | 2,044,982 |
Options Outstanding ,Weighted Average Remaining Contractual Life (in years) | '6 years 7 months 6 days |
Options Outstanding ,Weighted Average Exercise Price (in dollars per share) | $2.15 |
Options Exercisable, Number of Shares Exercisable (in shares) | 1,780,182 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $2.14 |
Range $2.50 - $2.70 [Member] | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract] | ' |
Range of Exercise Prices, Lower Range Limit (in dollars per share) | $2.50 |
Range of Exercise Prices, Upper Range Limit (in dollars per share) | $2.70 |
Options Outstanding, Number of Shares Outstanding (in shares) | 5,055,034 |
Options Outstanding ,Weighted Average Remaining Contractual Life (in years) | '7 years 8 months 23 days |
Options Outstanding ,Weighted Average Exercise Price (in dollars per share) | $2.63 |
Options Exercisable, Number of Shares Exercisable (in shares) | 3,083,900 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $2.62 |
Range $3.03 - $18.16 [Member] | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract] | ' |
Range of Exercise Prices, Lower Range Limit (in dollars per share) | $3.03 |
Range of Exercise Prices, Upper Range Limit (in dollars per share) | $18.16 |
Options Outstanding, Number of Shares Outstanding (in shares) | 308,759 |
Options Outstanding ,Weighted Average Remaining Contractual Life (in years) | '6 years 0 months 7 days |
Options Outstanding ,Weighted Average Exercise Price (in dollars per share) | $4.11 |
Options Exercisable, Number of Shares Exercisable (in shares) | 295,768 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $4.16 |
Range $18.18 - $57.44 [Member] | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract] | ' |
Range of Exercise Prices, Lower Range Limit (in dollars per share) | $18.18 |
Range of Exercise Prices, Upper Range Limit (in dollars per share) | $57.44 |
Options Outstanding, Number of Shares Outstanding (in shares) | 61,478 |
Options Outstanding ,Weighted Average Remaining Contractual Life (in years) | '2 years 8 months 1 day |
Options Outstanding ,Weighted Average Exercise Price (in dollars per share) | $35.61 |
Options Exercisable, Number of Shares Exercisable (in shares) | 61,478 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $35.61 |
Range $0.73 - $57.44 [Member] | ' |
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract] | ' |
Range of Exercise Prices, Lower Range Limit (in dollars per share) | $0.73 |
Range of Exercise Prices, Upper Range Limit (in dollars per share) | $57.44 |
Options Outstanding, Number of Shares Outstanding (in shares) | 10,306,671 |
Options Outstanding ,Weighted Average Remaining Contractual Life (in years) | '6 years 11 months 16 days |
Options Outstanding ,Weighted Average Exercise Price (in dollars per share) | $2.34 |
Options Exercisable, Number of Shares Exercisable (in shares) | 7,297,096 |
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $2.39 |
STOCKHOLDERS_EQUITY_Allocation
STOCKHOLDERS' EQUITY, Allocation of Recognized Period Costs (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation expense | $4,216 | $5,087 |
Cost of Revenue [Member] | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation expense | 263 | 230 |
Research And Development Expense [Member] | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation expense | 1,034 | 1,579 |
Selling, General and Administrative Expenses [Member] | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation expense | 2,257 | 3,146 |
Restructuring expense [Member] | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' |
Stock based compensation expense | $662 | $132 |
BENEFIT_PLANS_Details
BENEFIT PLANS (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Change in projected benefit obligation [Roll Forward] | ' | ' | ' |
Beginning benefit obligation | $692,000 | $450,000 | ' |
Service cost | 35,000 | 35,000 | ' |
Interest cost | 16,000 | 10,000 | ' |
Plan participants contributions | 21,000 | 14,000 | ' |
Foreign exchange adjustments | 16,000 | 19,000 | ' |
Actuarial loss (gain) | -132,000 | 77,000 | ' |
Transfer in | 0 | 87,000 | ' |
Ending benefit obligation | 648,000 | 692,000 | ' |
Change in plan assets [Roll Forward] | ' | ' | ' |
Beginning fair value of plan assets | 440,000 | 385,000 | ' |
Employer contributions | 21,000 | 14,000 | ' |
Plan participants contributions | 21,000 | 14,000 | ' |
Foreign exchange adjustments | 14,000 | 12,000 | ' |
Expected return on plan assets | 12,000 | -72,000 | ' |
Transfer in | 0 | 87,000 | ' |
Ending fair value of plan assets | 508,000 | 440,000 | ' |
Benefits paid | 0 | 0 | ' |
Funded status of plan [Abstract] | ' | ' | ' |
Projected benefit obligation | -648,000 | -692,000 | ' |
Fair value of plan assets | 508,000 | 440,000 | ' |
Funded status of the plan at the end of the year, recorded as a long-term liability | -140,000 | -252,000 | ' |
Defined benefit plan expected net periodic pension cost in next fiscal year | 23,000 | ' | ' |
Amount that will be amortized from accumulated other comprehensive income into net periodic benefit cost in next fiscal year | 10,000 | ' | ' |
Expected net periodic benefit cost [Abstract] | ' | ' | ' |
Service cost (net) | 30,000 | ' | ' |
Interest cost | 14,000 | ' | ' |
Expected return on plan assets | -11,000 | ' | ' |
Amortization [Abstract] | ' | ' | ' |
Actuarial (gain) | -10,000 | ' | ' |
Net periodic benefit cost | 23,000 | ' | ' |
Benefit obligation discount rate (in hundredths) | 2.25% | ' | ' |
Benefit obligation rate of compensation increase (in hundredths) | 2.00% | ' | ' |
Benefit obligation expected return on assets (in hundredths) | 2.25% | ' | ' |
Minimum interest rate on old age savings accounts as per Swiss pension law (in hundredths) | 1.50% | ' | ' |
Benefit obligation expected return on assets derived from insurance company surplus interest rate (in hundredths) | 0.75% | ' | ' |
Benefit cost discount rate (in hundredths) | 1.90% | ' | ' |
Benefit cost rate of compensation increase (in hundredths) | 2.00% | ' | ' |
Benefit cost expected return on assets (in hundredths) | 1.90% | ' | ' |
Net periodic benefit cost [Abstract] | ' | ' | ' |
Service cost (net) | 35,000 | 35,000 | ' |
Interest cost | 16,000 | 10,000 | ' |
Net periodic benefit cost | 51,000 | 45,000 | ' |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Employer anticipated contributions to the plan in next fiscal year | 22,000 | ' | ' |
Accrued severance liability | 30,000 | 168,000 | 696,000 |
Matching contribution by company | 59,000 | 28,000 | ' |
Israel Restructuring Plan [Member] | ' | ' | ' |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Cash surrender value of life insurance | 9,000 | ' | ' |
Employee severance costs | 0 | ' | ' |
Accrued severance liability | 15,000 | ' | ' |
Severance assets | $9,000 | ' | ' |
RESTRUCTURING_Details
RESTRUCTURING (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring reserve settled without cash | $662,000 | ' |
Restructuring reserve settled with cash | 288,000 | ' |
Restructuring charges | 950,000 | 93,000 |
Summary of restructuring activity [Roll forward] | ' | ' |
Beginning balance | 168,000 | 696,000 |
Charges | 950,000 | 207,000 |
Uses and adjustments | -1,088,000 | -735,000 |
Ending balance | 30,000 | 168,000 |
Palo Alto Restructuring [Member] | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and related cost, incurred cost | ' | 74,000 |
Endwave Corporation Restructuring [Member] | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' |
Restructuring and related cost, incurred cost | ' | $40,000 |
INCOME_TAXES_Details
INCOME TAXES (Details) (USD $) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Components of net loss before income taxes [Abstract] | ' | ' |
United States | $1,480,000 | ($6,156,000) |
International | -3,376,000 | -767,000 |
Loss before provision for income taxes | -1,896,000 | -6,923,000 |
Current [Abstract] | ' | ' |
United States | 37,000 | 115,000 |
International | 0 | 0 |
State | 13,000 | 2,000 |
Total | 50,000 | 117,000 |
Deferred [Abstract] | ' | ' |
United States | 0 | -36,000 |
International | 0 | 0 |
Total | 0 | -36,000 |
Provision for income taxes | 50,000 | 81,000 |
Effective income tax rate reconciliation [Abstract] | ' | ' |
Income tax at the federal statutory rate (in hundredths) | -34.00% | -34.00% |
State tax net of federal benefit (in hundredths) | 0.71% | 0.02% |
Foreign tax rate differential (in hundredths) | 60.55% | 4.19% |
Permanent items and other (in hundredths) | 1.93% | 1.67% |
Losses not benefited (in hundredths) | -26.55% | 29.29% |
Effective tax rate (in hundredths) | 2.64% | 1.17% |
Deferred tax asset (liability), net [Abstract] | ' | ' |
Net operating losses | 20,398,000 | 21,530,000 |
Tax credits | 3,022,000 | 3,022,000 |
Accrued and reserves | 1,872,000 | 2,139,000 |
Fixed assets | 966,000 | 847,000 |
Other | 2,176,000 | 1,506,000 |
Total deferred tax asset | 28,434,000 | 29,044,000 |
Valuation allowance | -27,587,000 | -27,898,000 |
Net deferred tax asset | 847,000 | 1,146,000 |
Deferred Tax Liabilities, Other Comprehensive Income | -40,000 | 0 |
Intangible assets | -847,000 | -1,146,000 |
Deferred tax liability | -887,000 | -1,146,000 |
Net deferred tax asset (liability) | -40,000 | 0 |
Valuation allowance change in amount | 311,000 | 1,400,000 |
Tax Credit Carryforward [Line Items] | ' | ' |
Accrued interest or penalties | 11,000 | 9,000 |
Unrecognized tax benefits that would impact effective tax rate | 2,800,000 | ' |
Income taxes payable | 368,000 | 331,000 |
Reconciliation amount of unrecognized tax benefits [Roll Forward] | ' | ' |
Balance at the Beginning | 2,523,000 | 2,065,000 |
Increases related to current year tax positions | 205,000 | 364,000 |
Increases related to prior year tax positions | 37,000 | 99,000 |
Decreases related to prior year tax positions | 0 | -5,000 |
Balance at the Ending | 2,765,000 | 2,523,000 |
Minimum [Member] | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' |
Operating loss carryforwards expiration dates | '2,014 | ' |
Maximum [Member] | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' |
Operating loss carryforwards expiration dates | '2,033 | ' |
Federal [Member] | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' |
Operating loss carryforwards | 42,900,000 | ' |
Tax Credit Carryforward [Line Items] | ' | ' |
Tax credit carryforward | 3,800,000 | ' |
State [Member] | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' |
Operating loss carryforwards | 27,200,000 | ' |
Foreign Tax Authority [Member] | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' |
Operating loss carryforwards | 13,600,000 | ' |
Tax Credit Carryforward [Line Items] | ' | ' |
Tax credit carryforward | $3,400,000 | ' |
NET_LOSS_PER_SHARE_Details
NET LOSS PER SHARE (Details) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' |
Outstanding anti-dilutive securities (in shares) | 13,088,711 | 12,110,029 |
Stock Options [Member] | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' |
Outstanding anti-dilutive securities (in shares) | 11,620,472 | 10,299,434 |
Common Stock Warrants [Member] | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' |
Outstanding anti-dilutive securities (in shares) | 1,468,239 | 1,810,595 |
SEGMENT_AND_GEOGRAPHIC_INFORMA2
SEGMENT AND GEOGRAPHIC INFORMATION (Details) (USD $) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | $28,926 | $36,734 |
Long-lived assets | 2,999 | 4,579 |
High-Speed Communications [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | 19,886 | 21,307 |
Industrial (ASIC) [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | 9,040 | 14,549 |
Government [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | 0 | 878 |
North America [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | 7,943 | 11,298 |
Asia [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | 7,700 | 9,731 |
Europe [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | 12,306 | 15,458 |
Other [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Total revenue | 977 | 247 |
United States [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Revenue by geographic region (in hundredths) | 24.00% | 28.00% |
Long-lived assets | 2,004 | 2,595 |
Switzerland [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Long-lived assets | $995 | $1,984 |
Italy [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Revenue by geographic region (in hundredths) | 39.00% | 21.00% |
Hungary [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Revenue by geographic region (in hundredths) | ' | 12.00% |
Japan [Member] | ' | ' |
Revenues from External Customers and Long-Lived Assets [Line Items] | ' | ' |
Revenue by geographic region (in hundredths) | 13.00% | 11.00% |
COMMITMENTS_AND_CONTINGENCIES_1
COMMITMENTS AND CONTINGENCIES (Details) (USD $) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
COMMITMENTS AND CONTINGENCIES [Abstract] | ' | ' | ' |
Facilities rent expense | $560,000 | $575,000 | ' |
Aggregate non-cancelable future minimum rental payments under capital leases [Abstract] | ' | ' | ' |
Capital leases, 2014 | 310,000 | ' | ' |
Capital leases, 2015 | 4,000 | ' | ' |
Capital leases, 2016 | 3,000 | ' | ' |
Capital leases, 2017 | 3,000 | ' | ' |
Capital leases, total minimum lease payments | 320,000 | ' | ' |
Less: Amount representing interest | -26,000 | ' | ' |
Total capital lease obligations | 294,000 | ' | ' |
Less: current portion | -284,000 | -324,000 | ' |
Long-term portion of capital lease obligations | 10,000 | 281,000 | ' |
Aggregate non-cancelable future minimum rental payments under operating leases [Abstract] | ' | ' | ' |
Operating leases, 2014 | 643,000 | ' | ' |
Operating leases, 2015 | 351,000 | ' | ' |
Operating leases, 2016 | 339,000 | ' | ' |
Operating leases, 2017 | 57,000 | ' | ' |
Operating leases, total minimum lease payments | 1,390,000 | ' | ' |
Gross and net book value of capital lease assets [Abstract] | ' | ' | ' |
Acquired cost | 1,666,000 | 1,653,000 | ' |
Accumulated amortization | -1,378,000 | -1,047,000 | ' |
Net book value | 288,000 | 606,000 | ' |
Approximate period of product warranty | '1 year | ' | ' |
Movement in Standard Product Warranty Accrual [Roll Forward] | ' | ' | ' |
Balance at January 1 | 330,000 | 612,000 | 296,000 |
Warranties accrued | 510,000 | 1,328,000 | ' |
Warranties settled or reversed | -792,000 | -1,012,000 | ' |
Balance at December 31 | $330,000 | $612,000 | $296,000 |
LEGAL_SETTLEMENTS_Details
LEGAL SETTLEMENTS (Details) (USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Sep. 29, 2013 |
Employee | |
LEGAL SETTLEMENTS [Abstract] | ' |
Number of former employees in legal settlement | 3 |
Special litigation-related income, net of legal fees | $7.25 |
SUBSEQUENT_EVENTS_Details
SUBSEQUENT EVENTS (Details) (Subsequent Event [Member]) | 0 Months Ended |
Feb. 10, 2014 | |
Subsequent Event [Line Items] | ' |
Term of joint venture | '30 years |
Renewal term of joint venture | '20 years |
Maximum [Member] | ' |
Subsequent Event [Line Items] | ' |
Period of written notice to terminate joint venture | '15 months |
Minimum [Member] | ' |
Subsequent Event [Line Items] | ' |
Period of written notice to terminate joint venture | '12 months |
BrPhotonics Produtos Optoeletronicos LTDA (BrP) [Member] | ' |
Subsequent Event [Line Items] | ' |
Percentage of capital owned by entity (in hundredths) | 49.00% |
Percentage of capital owned by CPqD (in hundredths) | 51.00% |